https://curecurrent.com/trials/outcomes-comparison-of-robotic-retropubic-and-perineal-prostatectomy-61001https://curecurrent.com/trials/arts-avodart-after-radical-therapy-for-prostate-cancer-study-61002https://curecurrent.com/trials/effects-of-anesthetic-technique-on-immune-and-inflammatory-systems-following-radical-prostatectomy-61003https://curecurrent.com/trials/intensity-modulated-radiation-therapy-in-treating-patients-with-stage-i-stage-ii-stage-iii-or-stage-iv-prostate-cancer-61004https://curecurrent.com/trials/open-label-extension-study-of-the-effects-of-pomegranate-extract-on-rising-psa-after-primary-therapy-for-prostate-cancer-61005https://curecurrent.com/trials/extension-to-study-of-effects-of-pomegranate-extract-on-rising-psa-levels-after-primary-therapy-for-prostate-cancer-61006https://curecurrent.com/trials/studying-stored-samples-from-patients-with-localized-prostate-cancer-treated-on-clinical-trial-nci-00-c-0154-61007https://curecurrent.com/trials/defined-green-tea-catechin-extract-in-treating-patients-with-localized-prostate-cancer-undergoing-surgery-61008https://curecurrent.com/trials/docetaxel-estramustine-and-thalidomide-in-treating-patients-with-androgen-independent-metastatic-adenocarcinoma-of-the-p-61009https://curecurrent.com/trials/a-study-of-mycobacterium-w-plus-docetaxel-for-hormone-refractory-metastatic-prostate-cancer-61010https://curecurrent.com/trials/tnferade-biologic-to-treat-locally-advanced-prostate-cancer-61011https://curecurrent.com/trials/spect-ct-guided-lymphatic-mapping-and-sentinel-lymphadenectomy-lm-sl-in-prostate-cancer-61012https://curecurrent.com/trials/comparing-pet-ct-using-c-11-choline-and-18f-fluoromethylcholine-in-patients-with-metastatic-prostate-cancer-61013https://curecurrent.com/trials/technetium-tc-99m-demobesin-4-for-imaging-procedures-in-patients-with-prostate-cancer-61014https://curecurrent.com/trials/phase-i-pre-radical-prostatectomy-rtvp-1-gene-therapy-for-prostate-cancer-61015https://curecurrent.com/trials/selenium-in-treating-patients-who-are-undergoing-brachytherapy-for-stage-i-or-stage-ii-prostate-cancer-61016https://curecurrent.com/trials/biochemical-recurrence-rate-of-radical-prostatectomy-combined-with-neoadjuvant-and-adjuvant-chemotherapy-in-high-risk-pr-61017https://curecurrent.com/trials/safety-and-effectiveness-study-of-docetaxel-and-zd1839-followed-by-removal-of-the-prostate-to-treat-prostate-cancer-61018https://curecurrent.com/trials/the-effects-of-epidural-anesthesia-on-the-bioavailability-of-nitric-oxide-and-renal-function-in-patients-undergoing-lapa-61019https://curecurrent.com/trials/evaluating-the-effect-of-the-vcd-on-erectile-function-and-penile-length-post-rrp-61020https://curecurrent.com/trials/selenomethionine-in-treating-patients-undergoing-surgery-or-internal-radiation-therapy-for-stage-i-or-stage-ii-prostate-61021https://curecurrent.com/trials/efficacy-study-of-risedronate-to-prevent-cancer-treatment-induced-bone-loss-in-prostate-cancer-61022https://curecurrent.com/trials/response-of-patients-on-surveillance-for-prostate-cancer-to-dutasteride-61023https://curecurrent.com/trials/feasibility-of-using-spect-ct-imaging-to-map-lymphatic-drainage-patterns-in-prostate-cancer-patients-61024https://curecurrent.com/trials/study-in-men-with-prostate-cancer-to-assess-the-safety-pharmacokinetics-and-testosterone-lowering-efficacy-of-tak-448-61025https://curecurrent.com/trials/vaccination-of-prostate-cancer-patients-with-muc-2-klh-conjugate-plus-the-immunological-adjuvant-qs21-61026https://curecurrent.com/trials/adjuvant-leuprolide-with-or-without-docetaxel-in-high-risk-prostate-cancer-after-radical-prostatectomy-61027https://curecurrent.com/trials/a-pragmatic-trial-of-the-effect-of-a-mailed-patient-flyer-about-prostate-specific-antigen-psa-testing-prior-to-an-annual-61028https://curecurrent.com/trials/a-trial-of-strontium-cisplatin-for-the-palliation-of-bone-pain-secondary-to-hormone-refractory-prostate-cancer-61029https://curecurrent.com/trials/short-course-hypofractionated-radiotherapy-for-localized-prostate-cancer-61030https://curecurrent.com/trials/phase-1-trial-of-ipilimumab-and-gvax-in-patients-with-metastatic-castration-resistant-prostate-cancer-61031https://curecurrent.com/trials/lucrin-depot-efficacy-and-safety-monitoring-study-in-patients-with-advanced-prostate-cancer-and-lower-urinary-tract-symp-61032https://curecurrent.com/trials/evaluation-of-arterial-pressure-based-cardiac-output-for-goal-directed-perioperative-therapy-61033https://curecurrent.com/trials/vaccine-therapy-of-prostate-cancer-patients-with-recombinant-soluble-prostate-specific-membrane-antigen-rs-psma-plus-the-61034https://curecurrent.com/trials/imaging-for-significant-prostate-cancer-risk-evaluation-61035https://curecurrent.com/trials/a-parallel-group-comparison-of-the-efficacy-and-safety-of-degarelix-at-two-different-dosing-regimens-in-patients-with-pr-61036https://curecurrent.com/trials/study-of-bafetinib-inno-406-as-treatment-for-patients-with-hormone-refractory-prostate-cancer-61037https://curecurrent.com/trials/biological-imaging-for-optimising-clinical-target-volume-ctv-and-gross-tumour-volume-gtv-contouring-in-prostate-cancer-t-61038https://curecurrent.com/trials/the-role-of-androgen-deprivation-treatment-adt-in-docetaxe-prednisolone-chemotherapy-for-castrate-resistant-prostatic-ca-61039https://curecurrent.com/trials/an-evaluation-of-polymer-based-fiducials-for-use-in-imaging-patients-receiving-treatment-for-prostate-cancer-61040https://curecurrent.com/trials/sutent-maintenance-after-response-to-taxotere-61041https://curecurrent.com/trials/human-telomerase-reverse-transcriptase-messenger-rna-htert-mrna-transfected-dendritic-cell-vaccines-61042https://curecurrent.com/trials/the-utility-of-psadv-psa-density-velocity-while-on-dutasteride-for-predicting-prostate-cancer-incidence-and-grade-and-st-61043https://curecurrent.com/trials/feasibility-study-of-a-dose-increase-by-a-boost-of-curietherapy-in-pulse-dose-rate-pdr-associated-with-the-extern-radiot-61044https://curecurrent.com/trials/study-on-lidocaine-vs-placebo-pain-control-during-transrectal-ultrasound-guided-prostate-biopsy-61045https://curecurrent.com/trials/comprehensive-analysis-of-hypoxia-in-prostate-cancer-diagnostic-markers-and-prognostic-significance-61046https://curecurrent.com/trials/carboplatin-etoposide-combination-in-hormone-resistant-prostate-cancers-61047https://curecurrent.com/trials/assessment-of-the-functional-significance-of-accessory-pudendal-arteries-61048https://curecurrent.com/trials/study-of-sgn-15-antibody-drug-conjugate-to-treat-hormone-refractory-prostate-cancer-61049https://curecurrent.com/trials/trastuzumab-and-docetaxel-in-treating-patients-who-have-metastatic-prostate-cancer-that-is-refractory-to-hormone-therapy-61050https://curecurrent.com/trials/study-using-cp-461-to-treat-advanced-prostate-cancer-61051https://curecurrent.com/trials/mri-mrsi-in-risk-assessment-of-prostate-cancer-patients-61052https://curecurrent.com/trials/uspio-enhanced-and-diffusion-weighted-mri-for-the-detection-of-pelvic-lymph-node-metastases-61053https://curecurrent.com/trials/a-phase-i-pilot-study-comparing-123i-mip-1072-versus-111in-capromab-pendetide-in-subjects-with-metastatic-prostate-cance-61054https://curecurrent.com/trials/study-to-evaluate-the-safety-pharmacokinetics-tissue-distribution-metabolism-and-dosimetry-of-two-prostate-cancer-imagin-61055https://curecurrent.com/trials/hypofractionated-radiotherapy-55-gy-16-fractions-4-weeks-for-localized-prostate-cancer-61056https://curecurrent.com/trials/athermal-nerve-sparing-during-robotic-assisted-radical-prostatectomy-using-a-hemostatic-matrix-61057https://curecurrent.com/trials/pro-state-search-for-a-protein-profile-corresponding-to-fast-developing-lesions-and-characterization-of-implicated-prote-61058https://curecurrent.com/trials/vitamin-d-effects-on-prostate-pathology-61059https://curecurrent.com/trials/isoflavone-in-prostate-specific-antigen-recurrent-prostate-cancer-61060https://curecurrent.com/trials/mitoxantrone-prednisone-plus-sorafenib-in-taxane-refractory-metastatic-hormone-refractory-prostate-cancer-hrpc-61061https://curecurrent.com/trials/combination-statin-acetylsalicylic-acid-and-dutasteride-use-in-prostate-cancer-61062https://curecurrent.com/trials/study-of-su011248-in-combination-with-docetaxel-taxotere-and-prednisone-in-patients-with-prostate-cancer-61063https://curecurrent.com/trials/early-start-of-oral-sildenafil-100mg-for-erectile-dysfunction-after-robotic-assisted-laparoscopic-radical-prostatectomy-61064https://curecurrent.com/trials/pomegranate-extract-in-treating-patients-with-rising-prostate-specific-antigen-levels-after-surgery-or-radiation-therapy-61065https://curecurrent.com/trials/bone-mineral-density-and-cancer-recurrence-in-patients-with-early-stage-prostate-cancer-61066https://curecurrent.com/trials/study-to-prevent-radiation-induced-damage-to-bowel-using-a-prebiotic-enhanced-diet-61067https://curecurrent.com/trials/histscanning-based-pdr-brachytherapy-in-prostate-cancer-histoscanning-based-interstitial-pdr-brachytherapy-61068https://curecurrent.com/trials/a-study-of-leuprolide-to-treat-prostate-cancer-61069https://curecurrent.com/trials/hyperbaric-oxygen-therapy-in-treating-long-term-gastrointestinal-adverse-effects-caused-by-radiation-therapy-in-patients-61070https://curecurrent.com/trials/prostate-cancer-imaging-with-radioactive-tracer-and-ultrasound-detector-compared-to-mri-and-prostascint-61071https://curecurrent.com/trials/a-phase-i-gene-therapy-study-of-fp253-fludarabine-for-prostate-cancer-61072https://curecurrent.com/trials/safety-and-efficacy-study-of-at-101-in-combination-with-docetaxel-and-prednisone-in-men-with-hrpc-61073https://curecurrent.com/trials/study-of-erlotinib-in-patients-with-non-metastatic-prostate-cancer-with-a-rising-prostate-specific-antigen-psa-on-hormon-61074https://curecurrent.com/trials/evaluation-of-mri-for-prostate-cancer-61075https://curecurrent.com/trials/comparison-study-of-mdx-010-ctla-4-alone-and-combined-with-docetaxel-in-the-treatment-of-patients-with-hormone-refractor-61076https://curecurrent.com/trials/novel-peptide-vaccination-for-patients-with-advanced-prostate-cancer-61077https://curecurrent.com/trials/the-biopres-trial-transrectal-biopsies-of-the-prostate-end-versus-side-firing-61078https://curecurrent.com/trials/two-doses-of-conjugated-estrogen-premarin-in-patients-with-androgen-independent-prostate-cancer-61079https://curecurrent.com/trials/pilot-efficacy-study-of-pi-88-with-docetaxel-to-treat-prostate-cancer-61080https://curecurrent.com/trials/a-phase-ii-trial-of-adjuvant-docetaxel-in-patients-at-high-risk-of-relapse-following-prostatectomy-61081https://curecurrent.com/trials/mri-targeted-focal-laser-thermal-therapy-of-prostate-cancer-followed-by-radical-prostatectomy-61082https://curecurrent.com/trials/study-investigating-the-pharmacokinetics-pharmacodynamics-and-safety-of-fe200486-61083https://curecurrent.com/trials/extension-study-investigating-the-long-term-safety-and-tolerability-of-repeat-doses-of-fe200486-in-prostate-cancer-patie-61084https://curecurrent.com/trials/pharmacokinetic-study-of-bay43-9006-and-taxotere-to-treat-patient-with-prostatic-cancer-61085https://curecurrent.com/trials/extension-study-investigating-the-long-term-safety-and-tolerability-of-repeat-doses-of-fe200486-in-prostate-cancer-patie-61086https://curecurrent.com/trials/study-investigating-the-long-term-safety-and-tolerability-of-repeated-doses-of-degarelix-in-prostate-cancer-patients-61087https://curecurrent.com/trials/aggressive-prostate-cancers-in-elderly-patients-61088https://curecurrent.com/trials/open-label-phase-ii-trial-of-mab-dose-escalation-of-bicalutamide-for-biochemical-failure-in-prostate-cancer-patients-61089https://curecurrent.com/trials/mitoxantrone-etoposide-and-vinorelbine-as-second-line-therapy-in-treating-patients-with-metastatic-prostate-cancer-that-61090https://curecurrent.com/trials/study-of-tamsulosin-and-or-dutasteride-to-relieve-urinary-symptoms-after-brachytherapy-for-localized-prostate-cancer-61091https://curecurrent.com/trials/adjuvant-docetaxel-and-estramustine-phosphate-for-high-risk-localized-prostate-cancer-61092https://curecurrent.com/trials/osteoporosis-among-men-treated-with-androgen-deprivation-for-prostate-cancer-61093https://curecurrent.com/trials/evaluation-of-radiation-therapy-positioning-system-rtps-in-patients-with-localized-prostate-cancer-61094https://curecurrent.com/trials/effect-of-zoledronic-acid-in-patients-with-prostate-cancer-and-bone-metastasis-61095https://curecurrent.com/trials/investigating-efficacy-and-safety-of-two-degarelix-three-month-dosing-regimens-in-patients-with-prostate-cancer-requirin-61096https://curecurrent.com/trials/open-label-randomised-parallel-group-study-61097https://curecurrent.com/trials/3d-recording-of-a-trans-rectal-prostate-biopsy-61098https://curecurrent.com/trials/selenium-and-prostate-cancer-clinical-trial-on-availability-to-prostate-tissue-and-effects-on-gene-expression-61099https://curecurrent.com/trials/xrp6258-plus-prednisone-compared-to-mitoxantrone-plus-prednisone-in-hormone-refractory-metastatic-prostate-cancer-61100https://curecurrent.com/trials/a-phase-i-ii-study-of-he3235-in-patients-with-prostate-cancer-61101https://curecurrent.com/trials/calcitriol-and-dexamethasone-in-treating-patients-with-prostate-cancer-who-have-undergone-surgery-or-radiation-therapy-61102https://curecurrent.com/trials/sentinel-lymph-node-detection-in-prostate-surgery-by-laparoscopy-61103https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-metastatic-prostate-cancer-that-has-not-responded-to-hormone-therapy-61104https://curecurrent.com/trials/study-of-radioimmunoguided-intensity-modulated-radiotherapy-imrt-for-prostate-cancer-61105https://curecurrent.com/trials/epidural-hydromorphone-compared-with-hydromorphone-infusion-in-treating-patients-with-prostate-cancer-undergoing-radical-61106https://curecurrent.com/trials/atrasentan-in-treating-patients-with-prostate-cancer-61107https://curecurrent.com/trials/magnetic-resonance-imaging-and-magnetic-resonance-spectroscopic-imaging-in-diagnosing-the-extent-of-disease-in-patients-61108https://curecurrent.com/trials/cone-beam-ct-for-daily-image-guidance-prostate-cancer-61109https://curecurrent.com/trials/observational-registry-of-treatment-patterns-in-castrate-resistant-prostate-cancer-crpc-patients-61110https://curecurrent.com/trials/exercise-in-men-with-prostate-cancer-61111https://curecurrent.com/trials/exercise-and-cognitive-psychosocial-functions-in-men-with-prostate-cancer-receiving-androgen-depletion-therapy-61112https://curecurrent.com/trials/safety-and-pharmacokinetics-of-orally-administered-gallium-maltolate-in-various-refractory-malignancies-61113https://curecurrent.com/trials/two-different-regimens-of-nolvadex-in-preventing-gynecomastia-induced-by-casodex-150-mg-in-patients-with-prostate-cancer-61114https://curecurrent.com/trials/a-phase-i-dose-escalation-study-of-bms-641988-in-patients-with-castration-resistant-prostate-cancer-61115https://curecurrent.com/trials/combination-casodex-and-iressa-in-locally-advanced-prostate-cancer-61116https://curecurrent.com/trials/a-phase-i-study-of-bms-641988-in-japanese-patients-with-castration-resistant-prostate-cancer-61117https://curecurrent.com/trials/study-to-assess-safety-and-tolerability-of-azd2171-after-multiple-doses-in-patients-with-advanced-prostate-cancer-61118https://curecurrent.com/trials/docetaxel-and-immunotherapy-prior-to-prostatectomy-for-high-risk-prostate-cancer-61119https://curecurrent.com/trials/extension-study-investigating-the-long-term-safety-of-degarelix-three-month-depots-in-patients-with-prostate-cancer-61120https://curecurrent.com/trials/prophylactic-urethral-stenting-with-memokath-after-prostate-implantation-for-prostate-adenocarcinoma-61121https://curecurrent.com/trials/bicalutamide-casodex-vs-placebo-in-non-metastatic-early-prostate-cancer-61122https://curecurrent.com/trials/a-comparative-study-of-degarelix-three-month-depot-in-three-different-dosing-regimens-in-patients-with-prostate-cancer-61123https://curecurrent.com/trials/quality-of-life-analysis-of-treatment-in-patients-with-prostate-cancer-on-adjuvant-zoladex-therapy-61124https://curecurrent.com/trials/observational-retrospective-trial-on-sequential-hormonal-therapy-in-patients-with-prostate-cancer-61125https://curecurrent.com/trials/combination-of-docetaxel-estramustine-hydrocortisone-versus-docetaxel-prednisone-in-patients-with-advanced-prostate-canc-61126https://curecurrent.com/trials/effects-of-alpha-blockers-on-prostate-specific-antigen-psa-change-in-men-with-lower-urinary-tract-symptoms-luts-61127https://curecurrent.com/trials/prostate-cancer-individual-signature-evaluation-trial-in-patients-undergoing-scheduled-prostate-biopsy-61128https://curecurrent.com/trials/a-safety-and-efficacy-study-of-prograf-in-the-prevention-of-erectile-dysfunction-after-radical-prostatectomy-61129https://curecurrent.com/trials/effect-of-adding-sufentanil-to-epidural-ropivacaine-on-perioperative-metabolic-and-stress-responses-in-combined-general-61130https://curecurrent.com/trials/a-study-comparing-at-101-in-combination-with-docetaxel-and-prednisone-versus-docetaxel-and-prednisone-in-men-with-chemot-61131https://curecurrent.com/trials/flutamide-suramin-and-hydrocortisone-in-treating-patients-with-prostate-cancer-61132https://curecurrent.com/trials/study-of-patupilone-in-prostate-cancer-patients-who-progress-after-hormone-therapy-and-docetaxel-chemotherapy-61133https://curecurrent.com/trials/awareness-to-osteopenia-s-treatment-by-bisphosphonate-in-male-suffering-from-prostate-cancer-61134https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-metastatic-prostate-cancer-that-has-not-responded-to-hormone-therapy-61135https://curecurrent.com/trials/prostate-cancer-androgen-deprivation-withdrawal-and-intermittent-chemotherapy-61136https://curecurrent.com/trials/impact-of-tamsulosin-on-voiding-patterns-following-early-catheter-removal-after-robot-assisted-laparoscopic-radical-pros-61137https://curecurrent.com/trials/evaluation-of-the-efficacy-and-safety-of-common-sage-in-controlling-hot-flashes-in-prostate-cancer-patients-treated-by-a-61138https://curecurrent.com/trials/transrectal-ultrasound-imaging-of-the-prostate-gland-and-neurovascular-bundles-during-robot-assisted-laparoscopic-radica-61139https://curecurrent.com/trials/efficacy-and-safety-study-of-a-new-leuprolide-acetate-17-mg-depot-to-treat-prostate-cancer-patients-61140https://curecurrent.com/trials/safety-and-efficacy-study-of-leuprolide-acetate-for-injectable-suspension-22-5-mg-in-the-treatment-of-prostate-cancer-61141https://curecurrent.com/trials/immunotherapy-with-apc8015-sipuleucel-t-provenge-for-asymptomatic-metastatic-hormone-refractory-prostate-cancer-61142https://curecurrent.com/trials/provenge-sipuleucel-t-active-cellular-immunotherapy-treatment-of-metastatic-prostate-cancer-after-failing-hormone-therap-61143https://curecurrent.com/trials/uci-03-72-prostate-cancer-detection-by-serum-proteomic-profiling-61144https://curecurrent.com/trials/a-study-of-single-agent-at-101-in-men-with-hormone-refractory-prostate-cancer-61145https://curecurrent.com/trials/biomarker-study-for-sunitinib-and-docetaxel-in-prostate-cancer-61146https://curecurrent.com/trials/shorter-radiation-schedule-for-the-treatment-of-prostate-cancer-61147https://curecurrent.com/trials/liposomal-doxorubicin-in-treating-patients-with-prostate-cancer-61148https://curecurrent.com/trials/mobicox-study-of-meloxicam-to-reduce-prostate-swelling-in-permanent-seed-prostate-brachytherapy-61149https://curecurrent.com/trials/endorectal-coil-magnetic-resonance-images-erc-mri-61150https://curecurrent.com/trials/preop-conformal-radiotherapy-prostate-61151https://curecurrent.com/trials/autologous-dendritic-cell-therapy-for-hormone-refractory-metastatic-prostate-cancer-61152https://curecurrent.com/trials/spaced-education-to-optimize-prostate-cancer-screening-61153https://curecurrent.com/trials/does-postoperative-gabapentin-reduce-pain-opioid-consumption-and-anxiety-and-have-a-positive-effect-on-health-related-qu-61154https://curecurrent.com/trials/a-study-of-bay-43-9006-in-combination-with-bicalutamide-in-patients-with-chemo-na-ve-hormone-refractory-prostate-cancer-61155https://curecurrent.com/trials/weekly-paclitaxel-low-dose-estramustine-and-carboplatin-in-the-treatment-of-hormone-refractory-prostate-carcinoma-61156https://curecurrent.com/trials/quality-of-life-in-men-undergoing-robotic-assisted-laparoscopic-radical-prostatectomy-versus-radical-retropubic-prostate-61157https://curecurrent.com/trials/weekly-docetaxel-and-bortezomib-in-the-treatment-of-advanced-hormone-refractory-prostate-cancer-61158https://curecurrent.com/trials/window-study-of-zd4054-in-metastatic-prostate-cancer-61159https://curecurrent.com/trials/functional-and-morphologic-mri-in-the-detection-of-prostate-cancer-in-patients-with-prior-negative-biopsy-61160https://curecurrent.com/trials/prevalence-of-osteoporosis-in-korean-prostate-cancer-patients-who-is-receiving-lhrh-agonist-and-or-anti-androgen-agent-61161https://curecurrent.com/trials/effects-of-gcp-on-prostate-cancer-61162https://curecurrent.com/trials/study-of-photodynamic-therapy-in-patients-with-prostate-cancer-following-radiation-therapy-61163https://curecurrent.com/trials/hypofractionated-radiotherapy-for-localized-prostate-cancer-with-cyberknife-or-with-imrt-61164https://curecurrent.com/trials/study-of-wst09-in-prostate-cancer-after-radiation-repeat-procedure-61165https://curecurrent.com/trials/phase-ii-iii-study-of-wst09-in-prostate-cancer-after-radiation-therapy-61166https://curecurrent.com/trials/atrasentan-and-zometa-for-men-with-prostate-cancer-metastatic-to-bone-61167https://curecurrent.com/trials/long-term-outcomes-of-alternative-brachytherapy-techniques-for-early-prostate-cancer-61168https://curecurrent.com/trials/impact-of-erythropoietin-treatment-versus-placebo-on-quality-of-life-in-patients-with-advanced-prostate-cancer-61169https://curecurrent.com/trials/adjuvant-docetaxel-zoledronic-acid-in-high-risk-early-prostate-cancer-following-prostatectomy-61170https://curecurrent.com/trials/evaluation-of-prostate-specific-antigen-psa-levels-in-patients-with-advanced-prostate-cancer-treated-with-bicalutamide-61171https://curecurrent.com/trials/androcur-effects-on-quality-of-life-61172https://curecurrent.com/trials/ultrasound-based-transperineal-robotic-biopsy-of-the-the-prostate-61173https://curecurrent.com/trials/a-phase-ii-trial-of-phenoxodiol-in-patients-with-castrate-and-non-castrate-prostate-cancer-61174https://curecurrent.com/trials/safety-of-lbh589-alone-and-in-combination-with-intravenous-docetaxel-and-prednisone-61175https://curecurrent.com/trials/the-effectiveness-of-18f-fluorocholine-positron-emission-tomography-pet-in-detecting-staging-and-following-up-prostate-c-61176https://curecurrent.com/trials/radiation-therapy-plus-amifostine-in-treating-patients-with-primary-prostate-cancer-61177https://curecurrent.com/trials/prevention-of-osteoporosis-in-men-with-prostate-cancer-61178https://curecurrent.com/trials/zante-zometa-and-taxotere-in-hormone-refractory-prostate-cancer-61179https://curecurrent.com/trials/computed-tomography-ct-scans-using-ct-on-rails-to-pinpoint-the-location-of-the-tumor-in-treating-patients-with-prostate-61180https://curecurrent.com/trials/exisulind-prior-to-radical-prostatectomy-61181https://curecurrent.com/trials/casodex-zoladex-hormonal-therapy-study-for-assessment-of-correlation-between-psa-bai-in-prostate-cancer-patients-61182https://curecurrent.com/trials/retrospective-non-interventional-study-of-depo-eligard-61183https://curecurrent.com/trials/prostate-cancer-screening-fostering-informed-decisions-61184https://curecurrent.com/trials/local-anesthesia-for-prostate-biopsy-61185https://curecurrent.com/trials/treatment-decision-making-in-early-stage-prostate-cancer-61186https://curecurrent.com/trials/isotretinoin-interferon-alfa-2b-docetaxel-and-estramustine-in-treating-patients-with-metastatic-prostate-cancer-that-did-61187https://curecurrent.com/trials/mri-guided-bone-marrow-biopsies-of-prostate-cancer-patients-61188https://curecurrent.com/trials/a-study-of-docetaxel-plus-carboplatin-in-patients-with-hormone-refractory-prostate-cancer-61189https://curecurrent.com/trials/mifepristone-ru-486-in-androgen-independent-prostate-cancer-61190https://curecurrent.com/trials/celecoxib-celebrex-versus-placebo-in-men-with-recurrent-prostate-cancer-61191https://curecurrent.com/trials/docetaxel-in-the-treatment-of-hormone-refractory-prostate-cancer-61192https://curecurrent.com/trials/docetaxel-in-hormone-refractory-prostate-cancer-hrpc-weekly-or-3weekly-tax-prednisone-in-hrpc-61193https://curecurrent.com/trials/maintaining-bone-strength-in-men-with-prostate-cancer-61194https://curecurrent.com/trials/open-label-trial-on-the-effect-of-i-v-zoledronic-acid-4-mg-on-bone-density-in-hormone-sensitive-prostate-cancer-patients-61195https://curecurrent.com/trials/a-prostate-cancer-study-in-men-undergoing-androgen-deprivation-therapy-61196https://curecurrent.com/trials/effects-of-octreotide-acetate-on-circulating-levels-of-chromogranin-a-in-advanced-prostate-cancer-patients-61197https://curecurrent.com/trials/exisulind-versus-placebo-after-surgical-removal-of-the-prostate-61198https://curecurrent.com/trials/multifunctional-magnetic-resonance-mr-for-radiotherapy-planning-in-prostate-cancer-61199https://curecurrent.com/trials/study-evaluating-the-correlation-between-c-11-acetate-uptake-and-retention-as-measured-by-pet-and-fas-in-prostate-cancer-61200https://curecurrent.com/trials/evaluation-of-the-effects-of-chemotherapy-on-the-uptake-and-retention-of-carbon-11-methionine-in-prostate-cancer-patient-61201https://curecurrent.com/trials/an-open-label-multi-center-phase-iia-trial-of-prx302-treatment-of-patients-with-locally-recurrent-prostate-cancer-after-61202https://curecurrent.com/trials/safety-and-efficacy-study-of-of-docetaxel-vs-docetaxel-estramustine-in-hormone-refractory-prostatic-cancer-61203https://curecurrent.com/trials/an-exploration-of-genetic-testing-for-prostate-cancer-susceptibility-61204https://curecurrent.com/trials/depiction-of-prostate-cancer-treatment-alternatives-in-greece-61205https://curecurrent.com/trials/monoclonal-antibody-therapy-in-treating-patients-with-prostate-cancer-that-has-not-responded-to-hormone-therapy-61206https://curecurrent.com/trials/phase-ii-trial-of-docetaxel-and-celecoxib-in-patients-with-androgen-independent-prostate-cancer-61207https://curecurrent.com/trials/japanese-study-of-the-combined-administration-of-docetaxel-with-prednisolone-for-metastatic-hormone-refractory-prostate-61208https://curecurrent.com/trials/prevention-of-urinary-incontinence-after-prostatectomy-61209https://curecurrent.com/trials/investigative-study-of-the-role-of-focal-therapy-for-prostate-cancer-treatment-61210https://curecurrent.com/trials/evaluation-of-serum-prostatic-specific-antigen-psa-after-cyproterone-compound-treatment-compared-with-oral-contraceptive-61211https://curecurrent.com/trials/far-infrared-radiation-treatment-for-prostate-cancer-61212https://curecurrent.com/trials/cancer-and-osteoporosis-research-with-alendronate-and-lupron-c-o-r-a-l-61213https://curecurrent.com/trials/normal-prostate-oxygenation-of-the-prostate-gland-in-men-undergoing-prostate-biopsy-61214https://curecurrent.com/trials/efficacy-of-fwge-in-combination-with-hormone-therapy-for-the-treatment-of-hormone-refractory-prostate-cancer-patients-61215https://curecurrent.com/trials/circulating-tumor-cells-and-survival-in-hormone-refractory-prostate-cancer-hrpc-patients-receiving-chemotherapy-61216https://curecurrent.com/trials/role-of-magnetic-resonance-imaging-mri-perfusion-to-detect-disease-in-prostate-carcinoma-61217https://curecurrent.com/trials/molecular-urine-tests-for-prostate-cancer-61218https://curecurrent.com/trials/casodex-vs-placebo-in-non-metastatic-early-prostate-cancer-61219https://curecurrent.com/trials/efficacy-and-safety-study-of-the-therapeutic-vaccine-pep223-in-prostate-cancer-patients-61220https://curecurrent.com/trials/retrospective-study-of-positive-biopsy-specimens-on-patients-undergoing-a-prostatectomy-61221https://curecurrent.com/trials/safety-study-to-explore-combination-of-gefitinib-zd1839-iressa-and-radiotherapy-in-non-metastatic-prostate-cancer-61222https://curecurrent.com/trials/open-label-trial-to-assess-iressa-in-prostate-cancer-patients-61223https://curecurrent.com/trials/gefitinib-in-the-treatment-of-the-first-relapse-of-prostate-cancer-beyond-prostatectomy-or-radiotherapy-61224https://curecurrent.com/trials/dose-seeking-trial-of-pck3145-in-asymptomatic-castrate-metastatic-prostate-cancer-patients-61225https://curecurrent.com/trials/neoadjuvant-therapy-with-docetaxel-and-ketoconazole-in-patients-with-high-risk-prostate-cancer-a-pilot-study-61226https://curecurrent.com/trials/phii-one-label-non-comparative-trial-in-metastatic-hormone-refractory-prostate-cancer-in-combination-with-prednisolone-61227https://curecurrent.com/trials/pedometer-and-exercise-study-in-prostate-cancer-patients-with-hormonal-therapy-61228https://curecurrent.com/trials/ascent-androgen-independent-prostate-cancer-study-of-calcitriol-enhancing-taxotere-61229https://curecurrent.com/trials/study-of-sorafenib-and-docetaxel-in-metastatic-prostate-cancer-61230https://curecurrent.com/trials/gvax-in-advanced-prostate-cancer-patients-made-lymphopenic-61231https://curecurrent.com/trials/multi-center-phase-ii-study-to-compare-mer-101-20mg-tablets-to-intravenous-zometa-4mg-in-male-bisphosphonate-naive-hormo-61232https://curecurrent.com/trials/quality-of-life-for-subjects-receiving-androgen-deprivation-therapy-and-have-a-doubling-in-psa-of-either-less-than-or-gr-61233https://curecurrent.com/trials/abarelix-versus-goserelin-plus-bicalutamide-in-patients-with-advanced-or-metastatic-prostate-cancer-61234https://curecurrent.com/trials/study-of-as1404-with-docetaxel-in-patients-with-hormone-refractory-metastatic-prostate-cancer-61235https://curecurrent.com/trials/short-or-long-schemes-of-antibiotic-prophylaxis-for-prostate-biopsy-61236https://curecurrent.com/trials/tumor-rna-transfected-dendritic-cell-vaccines-61237https://curecurrent.com/trials/a-study-of-picoplatin-and-docetaxel-in-subjects-with-prostate-cancer-61238https://curecurrent.com/trials/calcifidol-therapy-in-men-with-cancer-61239https://curecurrent.com/trials/phase-ii-study-of-rad001-in-a-neoadjuvant-setting-in-men-with-intermediate-or-high-risk-prostate-cancer-61240https://curecurrent.com/trials/study-of-prostate-cancer-in-black-and-white-u-s-veterans-61241https://curecurrent.com/trials/neoadjuvant-estradiol-or-androgen-deprivation-in-clinically-localized-prostate-cancer-61242https://curecurrent.com/trials/evaluation-of-sr-31747a-versus-placebo-in-androgen-independent-non-metastatic-prostate-cancer-61243https://curecurrent.com/trials/study-of-docetaxel-153-sm-edtmp-in-patients-with-hormone-refractory-prostate-cancer-61244https://curecurrent.com/trials/effect-of-nightly-versus-prn-sildenafil-on-early-return-of-erectile-function-following-laparoscopic-radical-prostatectom-61245https://curecurrent.com/trials/laparoscopic-vs-open-prostatectomy-outcomes-61246https://curecurrent.com/trials/efficacy-and-pharmacodynamic-study-of-panzem-ncd-in-patients-with-hormone-refractory-prostate-cancer-61247https://curecurrent.com/trials/evaluate-the-effects-of-gpi-1485-on-erectile-function-following-bilateral-nerve-sparing-prostatectomy-61248https://curecurrent.com/trials/changes-in-prostate-specific-antigen-levels-during-synergo-therapy-intravesical-chemotherapy-instillations-combined-with-61249https://curecurrent.com/trials/gvax-vaccine-for-prostate-cancer-vs-docetaxel-prednisone-in-patients-with-metastatic-hormone-refractory-prostate-cancer-61250https://curecurrent.com/trials/a-prospective-longitudinal-study-of-health-related-quality-of-life-in-men-with-clinically-localized-prostate-cancer-61251https://curecurrent.com/trials/to-explore-racial-differences-in-potential-risk-factors-for-developing-prostate-cancer-in-the-va-population-61252https://curecurrent.com/trials/a-prospective-randomized-phase-iii-study-comparing-hormonal-therapy-docetaxel-61253https://curecurrent.com/trials/synthetic-genistein-bonistein-in-patients-who-are-undergoing-surgery-for-prostate-cancer-61254https://curecurrent.com/trials/docetaxel-in-combination-with-gvax-immunotherapy-versus-docetaxel-and-prednisone-in-prostate-cancer-patients-61255https://curecurrent.com/trials/study-of-a-6-month-sustained-release-formulation-of-leuprolide-acetate-in-prostate-cancer-61256https://curecurrent.com/trials/study-of-kos-862-epothilone-d-in-metastatic-prostate-cancer-61257https://curecurrent.com/trials/evaluation-of-transgenic-lymphocyte-immunization-vaccine-in-subjects-with-prostate-adenocarcinoma-61258https://curecurrent.com/trials/angelica-sinensis-for-the-treatment-of-hot-flashes-in-men-undergoing-lhrh-therapy-for-prostate-cancer-61259https://curecurrent.com/trials/bone-loss-in-men-on-androgen-blockade-as-adjuvant-therapy-for-prostate-cancer-61260https://curecurrent.com/trials/dha-paclitaxel-in-treating-patients-with-metastatic-prostate-cancer-61261https://curecurrent.com/trials/a-randomized-trial-of-external-beam-radiotherapy-versus-cryoablation-in-patients-with-localized-prostate-cancer-61262https://curecurrent.com/trials/vector-delivery-of-the-il-12-gene-in-men-with-prostate-cancer-61263https://curecurrent.com/trials/casodex-150-mg-compassionate-use-trial-for-subjects-with-prostate-cancer-61264https://curecurrent.com/trials/radiotherapy-for-prostate-cancer-conventional-dose-versus-high-dose-61265https://curecurrent.com/trials/study-of-individualized-amonafide-to-treat-prostate-cancer-61266https://curecurrent.com/trials/chemotherapy-hormone-therapy-and-surgery-to-remove-the-prostate-gland-in-patients-with-high-risk-prostate-cancer-61267https://curecurrent.com/trials/influence-of-hormone-therapy-on-heart-attack-incidence-in-men-undergoing-prostate-brachytherapy-61268https://curecurrent.com/trials/sclerotherapy-of-internal-spermatic-veins-in-patients-with-varicocele-and-localized-prostate-cancer-61269https://curecurrent.com/trials/shared-decision-making-for-prostate-cancer-screening-a-practice-based-randomized-controlled-trial-61270https://curecurrent.com/trials/familial-prostate-cancer-61271https://curecurrent.com/trials/analysis-of-prostate-cancer-short-term-cultures-using-molecular-cytogenetic-methods-61272https://curecurrent.com/trials/a-phase-ii-trial-of-leuprolide-flutamide-suramin-in-untreated-poor-prognosis-prostate-carcinoma-61273https://curecurrent.com/trials/a-phase-i-study-of-recombinant-vaccinia-virus-that-expresses-prostate-specific-antigen-in-adult-patients-with-adenocarci-61274https://curecurrent.com/trials/a-pharmacokinetic-study-of-genistein-a-tyrosine-kinase-inhibitor-61275https://curecurrent.com/trials/a-randomized-phase-ii-study-of-oral-thalidomide-in-patients-with-hormone-refractory-prostate-cancer-61276https://curecurrent.com/trials/markers-for-early-detection-of-prostate-cancer-61277https://curecurrent.com/trials/phase-i-ii-dose-escalation-study-of-velcade-and-docetaxel-in-patients-with-advanced-androgen-independent-prostate-cancer-61278https://curecurrent.com/trials/study-of-atn-224-in-patients-with-prostate-cancer-61279https://curecurrent.com/trials/clinical-trial-for-prostate-cancer-61280https://curecurrent.com/trials/medi-522-in-the-treatment-of-patients-with-metastatic-androgen-independent-prostate-cancer-61281https://curecurrent.com/trials/diet-genetic-variation-and-prostate-cancer-among-african-americans-61282https://curecurrent.com/trials/an-open-label-exploratory-study-in-newly-diagnosed-prostate-cancer-patients-61283https://curecurrent.com/trials/dose-escalation-and-efficacy-trial-of-gvax-prostate-cancer-vaccine-61284https://curecurrent.com/trials/study-of-samarium-sm-153-lexidronam-combined-with-docetaxel-for-patients-with-prostate-cancer-61285https://curecurrent.com/trials/psychostimulants-for-fatigue-in-prostate-cancer-61286https://curecurrent.com/trials/a-long-term-safety-study-with-atrasentan-61287https://curecurrent.com/trials/immunotherapy-after-chemotherapy-for-patients-with-hormone-refractory-metastatic-prostate-cancer-61288https://curecurrent.com/trials/study-of-aranesp-to-treat-anemia-in-prostate-cancer-patients-61289https://curecurrent.com/trials/bi-weekly-administration-of-docetaxel-for-older-men-with-hormone-refractory-prostate-cancer-61290https://curecurrent.com/trials/leuprolide-acetate-3-75-mg-depot-to-treat-prostate-cancer-61291https://curecurrent.com/trials/dn-101-in-combination-with-docetaxel-in-androgen-independent-prostate-cancer-aipc-aipc-study-of-calcitriol-enhancing-tax-61292https://curecurrent.com/trials/bicalutamide-monotherapy-has-significant-quality-of-life-benefits-for-men-with-advanced-prostate-cancer-61293https://curecurrent.com/trials/radical-radiotherapy-by-external-beam-radiation-versus-radical-radiotherapy-with-temporary-iridium-implant-plus-external-61294https://curecurrent.com/trials/pcmri-an-mri-trus-system-for-the-evaluation-of-the-prostate-61295https://curecurrent.com/trials/survival-outcomes-and-tumor-molecular-profile-following-bicalutamide-neoadjuvant-therapy-61296https://curecurrent.com/trials/positive-surgical-margins-rate-and-egfr-family-members-expression-in-prostate-cancer-treated-with-bicalutamide-61297https://curecurrent.com/trials/evaluation-of-qol-tolerability-and-use-of-zoladex-10-8-safesystem-for-advanced-pca-german-ipep-trial-61298https://curecurrent.com/trials/docetaxel-and-gemcitabine-in-hormonal-refractory-metastatic-prostate-cancer-61299https://curecurrent.com/trials/changes-in-bone-mineral-density-and-fracture-risk-in-patients-receiving-androgen-deprivation-therapy-for-prostate-cancer-61300https://curecurrent.com/trials/broccoli-peas-and-pin-61301https://curecurrent.com/trials/safety-study-of-a-radiolabeled-antibody-7e11-in-patients-with-progressive-hormone-refractory-prostate-cancer-61302https://curecurrent.com/trials/early-detection-of-prostate-cancer-by-facs-61303https://curecurrent.com/trials/cmab-vs-imab-in-metastatic-prostate-cancer-61304https://curecurrent.com/trials/frequency-of-zoledronic-acid-to-prevent-further-bone-loss-in-osteoporotic-patients-requiring-androgen-deprivation-therap-61305https://curecurrent.com/trials/study-of-atrasentan-in-men-with-non-metastatic-hormone-refractory-prostate-cancer-61306https://curecurrent.com/trials/a-pilot-study-evaluating-oral-triamcinalone-in-patients-with-androgen-independent-prostate-cancer-61307https://curecurrent.com/trials/mln2704-in-subjects-with-metastatic-androgen-independent-prostate-cancer-61308https://curecurrent.com/trials/i-125-versus-pd-103-for-low-risk-prostate-cancer-61309https://curecurrent.com/trials/high-versus-low-dose-supplemental-external-radiation-with-pd-103-for-prostate-cancer-61310https://curecurrent.com/trials/i-125-versus-pd-103-for-medium-risk-prostate-cancer-61311https://curecurrent.com/trials/casodex-zoladex-biomarkers-in-localised-prostate-cancer-61312https://curecurrent.com/trials/a-trial-of-mln2704-in-subjects-with-metastatic-androgen-independent-prostate-cancer-61313https://curecurrent.com/trials/annexin-a3-anxa3-as-protein-based-marker-for-non-invasive-molecular-diagnostics-of-prostate-carcinoma-61314https://curecurrent.com/trials/a-randomized-study-of-the-efficacy-of-low-venous-pressure-general-anesthesia-versus-combined-spinal-epidural-anesthesia-61315https://curecurrent.com/trials/phase-ii-trial-of-monoclonal-antibody-j591-in-combination-with-low-dose-subcutaneous-interleukin-2-61316https://curecurrent.com/trials/active-surveillance-for-prostate-cancer-with-indolent-features-61317https://curecurrent.com/trials/safety-and-efficacy-of-cc-4047-in-subjects-with-metastatic-hormone-refractory-prostate-cancer-hrpc-61318https://curecurrent.com/trials/liposomal-doxorubicin-and-estramustine-phosphate-study-in-taxane-resistant-hormone-refractory-advanced-prostate-cancer-61319https://curecurrent.com/trials/vaccine-study-of-mva-muc1-il2-in-patients-with-prostate-cancer-61320https://curecurrent.com/trials/ivig-in-the-treatment-of-metastatic-cancers-of-the-prostate-colon-and-melanoma-61321https://curecurrent.com/trials/the-plenaxis-experience-study-61322https://curecurrent.com/trials/study-of-abarelix-in-androgen-independent-prostate-cancer-progressing-after-agonist-therapy-61323https://curecurrent.com/trials/investigation-of-early-hormonotherapy-efficacy-of-prostate-cancer-61324https://curecurrent.com/trials/study-of-peri-operative-docetaxel-plus-laparoscopic-radical-prostatectomy-in-prostate-cancer-patients-61325https://curecurrent.com/trials/safety-and-efficacy-of-atrasentan-in-men-with-hormone-naive-prostate-cancer-exhibiting-early-signs-of-biochemical-failur-61326https://curecurrent.com/trials/a-study-of-atrasentan-in-men-with-metastatic-hormone-refractory-prostate-cancer-61327https://curecurrent.com/trials/postoperative-telerounding-a-multi-center-prospective-randomized-assessment-of-patient-outcomes-and-satisfaction-61328https://curecurrent.com/trials/effects-of-n-methyl-d-aspartate-nmda-receptor-antagonism-on-hyperalgesia-opioid-use-and-pain-after-radical-prostatectomy-61329https://curecurrent.com/trials/finnprostate-study-vii-intermittent-versus-continuous-androgen-deprivation-in-patients-with-advanced-prostate-cancer-61330https://curecurrent.com/trials/intravenous-cg7870-in-combination-with-docetaxel-in-patients-with-metastatic-hormone-refractory-prostate-cancer-61331https://curecurrent.com/trials/pr-7-companion-trial-effect-of-intermittent-versus-continuous-androgen-suppression-on-bone-loss-and-body-composition-61332https://curecurrent.com/trials/palladium-103-seed-implant-and-single-daily-dosing-of-uroxatral-vs-twice-daily-dosing-of-flomax-a-3-month-retrospective-61333https://curecurrent.com/trials/application-of-genetic-polymorphisms-of-dna-repair-in-the-prediction-of-prostate-cancer-susceptibility-and-its-clinical-61334https://curecurrent.com/trials/a-multicenter-single-arm-open-label-study-to-evaluate-the-safety-and-efficacy-of-single-agent-lenalidomide-revlimid-cc-5-61335https://curecurrent.com/trials/a-study-of-epirubicin-with-estramustine-phosphate-and-celecoxib-for-the-treatment-of-prostate-cancer-61336https://curecurrent.com/trials/a-phase-ii-trial-of-combination-therapy-with-celecoxib-and-taxotere-for-the-treatment-of-stage-d3-prostate-cancer-61337https://curecurrent.com/trials/a-randomized-controlled-trial-to-promote-physician-patient-discussion-of-prostate-cancer-screening-61338https://curecurrent.com/trials/prophylactic-vs-therapeutic-use-of-uroxatrol-in-men-undergoing-brachytherapy-61339https://curecurrent.com/trials/mr-lymphography-and-lymph-node-staging-in-prostate-cancer-61340https://curecurrent.com/trials/cd-rom-intervention-for-prostate-cancer-screening-61341https://curecurrent.com/trials/family-history-in-prostate-cancer-patients-in-taiwan-61342https://curecurrent.com/trials/prime-boost-dose-scheduling-trial-for-human-gm-csf-gene-transduced-irradiated-prostate-allogeneic-cancer-cell-vaccines-a-61343https://curecurrent.com/trials/vaccination-priming-and-vaccine-boosting-trial-of-allogeneic-human-gm-csf-gene-transduced-irradiated-prostate-cancer-cel-61344https://curecurrent.com/trials/prime-boost-dose-scheduling-trial-for-human-gm-csf-gene-transduced-irradiated-prostate-allogeneic-cancer-vaccine-allogen-61345https://curecurrent.com/trials/a-study-to-assess-the-efficacy-of-tadalafil-to-treat-erectile-dysfunction-after-radiotherapy-of-prostate-cancer-61346https://curecurrent.com/trials/trial-of-iv-injection-of-cv787-in-hormone-refractory-metastatic-prostate-cancer-61347https://curecurrent.com/trials/a-safety-and-feasibility-study-of-active-immunotherapy-in-patients-with-metastatic-prostate-carcinoma-using-autologous-d-61348https://curecurrent.com/trials/follow-up-study-for-men-diagnosed-with-prostate-cancer-through-participation-in-a-prostate-specific-antigen-screening-pr-61349https://curecurrent.com/trials/abx-egf-a-monoclonal-antibody-given-to-patients-with-prostate-cancer-with-or-without-tumor-in-other-parts-of-the-body-61350https://curecurrent.com/trials/amyloid-pet-imaging-in-the-baltimore-longitudinal-study-of-aging-61351https://curecurrent.com/trials/the-effect-of-combination-of-mediterranean-diet-and-oleocanthal-in-patients-with-mild-cognitive-impairment-61352https://curecurrent.com/trials/exploratory-study-of-low-dose-whole-brain-radiation-therapy-with-helaxon-1x-in-patients-with-mild-alzheimer-s-disease-de-61353https://curecurrent.com/trials/pet-imaging-of-phosphodiesterase-4-pde4-in-volunteers-with-alzheimer-disease-ad-or-mild-cognitive-impairment-mci-61354https://curecurrent.com/trials/sniff-combo-ini-empa-trial-61355https://curecurrent.com/trials/study-of-lhp588-in-subjects-with-p-gingivalis-positive-alzheimer-s-disease-61356https://curecurrent.com/trials/study-to-test-effects-and-safety-of-ro7568282-in-early-symptomatic-alzheimer-s-disease-61357https://curecurrent.com/trials/a-study-of-remternetug-ly3372993-in-early-alzheimer-s-disease-trailrunner-alz-3-61358https://curecurrent.com/trials/neuroplasticity-enhancement-from-cognitive-training-reinforced-by-psilocybin-61359https://curecurrent.com/trials/high-definition-transcranial-direct-current-stimulation-hd-tdcs-for-early-alzheimer-s-disease-61360https://curecurrent.com/trials/lio-ad-lithium-orotate-in-alzheimers-disease-feasibility-biomarker-engagement-and-clinical-response-61361https://curecurrent.com/trials/a-grief-support-app-for-adults-experiencing-bereavement-61362https://curecurrent.com/trials/inrad-observational-study-61363https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-karxt-karx-ec-for-cognitive-impairment-in-alzheimer-s-disease-61364https://curecurrent.com/trials/the-brain-health-study-a-pragmatic-patient-centered-trial-61365https://curecurrent.com/trials/a-study-to-confirm-safety-and-efficacy-of-lecanemab-in-participants-with-early-alzheimer-s-disease-61366https://curecurrent.com/trials/ultrasonic-debris-clearance-to-promote-brain-resilience-61367https://curecurrent.com/trials/study-to-evaluate-the-efficacy-safety-and-tolerability-of-bms-986368-for-the-treatment-of-agitation-in-participants-with-61368https://curecurrent.com/trials/evaluation-of-a-decision-support-tool-for-blood-biomarker-testing-for-alzheimer-s-disease-in-primary-care-61369https://curecurrent.com/trials/acp-204-in-adults-with-alzheimer-s-disease-psychosis-61370https://curecurrent.com/trials/impact-of-therapeutic-educational-programme-on-the-alzheimer-s-disease-affected-patient-s-quality-of-life-61371https://curecurrent.com/trials/cervical-lymphatic-microsurgery-in-alzheimer-s-disease-61372https://curecurrent.com/trials/effect-of-10-mg-xanamem-on-dementia-due-to-alzheimer-s-disease-61373https://curecurrent.com/trials/escalating-doses-of-memantine-in-down-syndrome-meds-123-61374https://curecurrent.com/trials/dominantly-inherited-alzheimer-network-dian-61375https://curecurrent.com/trials/aging-and-exercise-impacts-on-glymphatic-function-61376https://curecurrent.com/trials/a-scalable-nutrition-adherence-intervention-61377https://curecurrent.com/trials/negotiation-training-for-family-caregivers-of-people-with-alzheimer-s-disease-61378https://curecurrent.com/trials/novel-brain-stimulation-treatment-for-neuropsychiatric-symptoms-in-alzheimer-s-disease-61379https://curecurrent.com/trials/clinical-study-of-snk01-in-participants-with-moderate-alzheimer-s-disease-61380https://curecurrent.com/trials/non-invasive-neurostimulation-as-a-tool-for-diagnostics-and-management-for-neurodegenerative-diseases-61381https://curecurrent.com/trials/ipath-for-cp-pilot-61382https://curecurrent.com/trials/inherited-diseases-caregiving-and-social-networks-61383https://curecurrent.com/trials/bisnorcymserine-in-healthy-adult-volunteers-61384https://curecurrent.com/trials/restoring-cervical-lymphatic-drainage-in-alzheimer-s-disease-61385https://curecurrent.com/trials/autophagy-enhancers-to-reduce-sleep-disturbances-61386https://curecurrent.com/trials/mediterranean-dash-intervention-for-neurodegenerative-delay-mind-diet-in-stroke-patients-patients-61387https://curecurrent.com/trials/to-evaluate-the-safety-and-efficacy-of-rp902-tablets-61388https://curecurrent.com/trials/improving-sleep-and-cognition-in-alzheimer-s-disease-61389https://curecurrent.com/trials/non-invasive-brain-stimulation-for-memory-loss-in-early-alzheimer-s-disease-61390https://curecurrent.com/trials/a-study-to-assess-the-efficacy-and-safety-of-ml-007c-ma-for-the-treatment-of-alzheimer-s-disease-psychosis-61391https://curecurrent.com/trials/clinical-trial-on-agitation-in-alzheimer-s-dementia-61392https://curecurrent.com/trials/restoring-vascular-and-insulin-function-to-augment-anti-amyloid-therapy-in-alzheimer-s-disease-61393https://curecurrent.com/trials/duvax-a-phase-1-alzheimer-s-vaccine-study-targeting-amyloid-beta-and-tau-61394https://curecurrent.com/trials/study-in-subjects-with-mild-to-moderate-alzheimer-s-dementia-61395https://curecurrent.com/trials/multimodal-ophthalmic-imaging-and-plasma-biomarkers-for-the-early-detection-of-alzheimer-s-disease-61396https://curecurrent.com/trials/neuroprotective-effects-of-oleanolic-acid-and-erythrodiol-in-prodromal-alzheimer-s-disease-61397https://curecurrent.com/trials/choose-myself-before-losing-myself-61398https://curecurrent.com/trials/a-study-to-assess-the-efficacy-and-safety-of-iti-1284-in-the-treatment-of-psychosis-associated-with-alzheimer-s-disease-61399https://curecurrent.com/trials/the-gut-pro-study-61400https://curecurrent.com/trials/alzheimer-s-disease-neuroimaging-initiative-4-61401https://curecurrent.com/trials/indian-transforming-alzheimer-s-care-training-intact-61402https://curecurrent.com/trials/open-label-extension-study-to-assess-the-long-term-safety-and-tolerability-of-karxt-in-subjects-with-psychosis-associate-61403https://curecurrent.com/trials/an-efficacy-and-safety-study-of-alz-801-in-apoe4-4-early-ad-subjects-61404https://curecurrent.com/trials/a-study-to-assess-the-efficacy-and-safety-of-iti-1284-in-the-treatment-of-agitation-associated-with-alzheimer-s-dementia-61405https://curecurrent.com/trials/impact-of-a-multimodal-lifestyle-intervention-on-dementia-risk-factors-and-attitude-related-to-dementia-risk-a-logistica-61406https://curecurrent.com/trials/a-study-of-ly4560736-in-healthy-participants-and-participants-with-alzheimer-s-disease-ad-61407https://curecurrent.com/trials/randomized-study-to-evaluate-the-effect-of-obicetrapib-in-participants-with-preclinical-alzheimer-s-disease-61408https://curecurrent.com/trials/disease-modifying-potential-of-5mg-of-melatonin-on-cognition-and-brain-health-in-aging-61409https://curecurrent.com/trials/blood-biomarkers-for-screening-of-alzheimer-s-disease-61410https://curecurrent.com/trials/effectiveness-of-the-arth-e-application-for-exercise-adherence-in-people-with-knee-osteoarthritis-rct-61411https://curecurrent.com/trials/a-study-to-evaluate-the-long-term-efficacy-and-safety-of-karxt-karx-ec-for-agitation-in-alzheimer-s-disease-adagio-3-61412https://curecurrent.com/trials/the-effect-of-urolithin-a-mitopure-on-alzheimer-s-disease-61413https://curecurrent.com/trials/thrive-at-home-a-virtual-reality-social-intervention-for-older-adults-61414https://curecurrent.com/trials/improving-pcp-advance-care-planning-for-people-with-adrd-61415https://curecurrent.com/trials/a-clinical-trial-of-trontinemab-in-participants-with-early-symptomatic-alzheimer-s-disease-61416https://curecurrent.com/trials/a-study-of-jnj-64042056-in-participants-with-preclinical-alzheimer-s-disease-61417https://curecurrent.com/trials/precuneus-mapping-with-sinaptistim-an-investigational-tms-eeg-system-in-mild-to-moderate-ad-patients-61418https://curecurrent.com/trials/a-study-of-trontinemab-in-participants-with-early-symptomatic-alzheimer-s-disease-61419https://curecurrent.com/trials/jigsawdio-multisensory-platform-for-people-with-mild-cognitive-impairment-alzheimer-s-disease-or-related-dementias-61420https://curecurrent.com/trials/single-center-prospective-longitudinal-study-of-taste-in-patients-with-cognitive-disorders-at-different-stages-of-severi-61421https://curecurrent.com/trials/a-study-of-ono-2020-in-patients-with-agitation-associated-with-alzheimer-s-disease-dementia-61422https://curecurrent.com/trials/a-study-of-zunveyl-on-safety-tolerability-neuropsychiatric-symptoms-and-caregiver-distress-in-alzheimer-s-disease-resolv-61423https://curecurrent.com/trials/active-gains-in-brain-using-exercise-during-aging-61424https://curecurrent.com/trials/a-study-of-donanemab-ly3002813-in-participants-with-early-symptomatic-alzheimer-s-disease-61425https://curecurrent.com/trials/a-study-of-retinal-imaging-to-detect-abnormal-protein-deposits-associated-with-alzheimer-s-disease-61426https://curecurrent.com/trials/a-study-of-ly3439539-in-participants-with-alzheimer-s-disease-61427https://curecurrent.com/trials/av-1959r-vaccine-in-individuals-with-preclinical-alzheimer-s-disease-61428https://curecurrent.com/trials/a-study-to-evaluate-the-drug-levels-absolute-bioavailability-safety-tolerability-and-immunogenicity-of-single-dose-of-bm-61429https://curecurrent.com/trials/autologous-activated-adipose-derived-stem-cells-rb-adsc-injected-directly-into-the-brain-for-mild-to-moderate-alzheimer-61430https://curecurrent.com/trials/2-hydroxybenzylamine-2-hoba-study-in-early-alzheimer-s-patients-61431https://curecurrent.com/trials/transcranial-alternating-current-stimulation-tacs-combined-with-cognitive-training-in-alzheimer-s-disease-61432https://curecurrent.com/trials/a-phase-2-study-to-assess-the-safety-of-ei-1071-and-the-effects-of-ei-1071-on-neuroinflammation-in-alzheimer-s-disease-p-61433https://curecurrent.com/trials/interleukine-2-il-2-plus-semaglutide-in-alzheimer-s-disease-61434https://curecurrent.com/trials/web-based-insomnia-treatment-for-spousal-dementia-caregivers-shuti-dc-61435https://curecurrent.com/trials/improving-memory-in-alzheimer-s-disease-with-noninvasive-brain-stimulation-61436https://curecurrent.com/trials/combating-alzheimer-s-through-sleep-and-exercise-61437https://curecurrent.com/trials/evaluation-of-nbi-1117567-in-participants-with-mild-to-moderate-alzheimer-s-disease-ad-taking-a-background-acetylcholine-61438https://curecurrent.com/trials/a-study-to-investigate-the-safety-and-effectiveness-of-sar448851-in-participants-with-early-alzheimer-s-disease-61439https://curecurrent.com/trials/a-study-of-ly4405094-in-healthy-participants-and-participants-with-alzheimer-s-disease-61440https://curecurrent.com/trials/a-post-authorization-registry-study-of-participants-treated-with-leqembi-61441https://curecurrent.com/trials/near-infrared-light-therapy-device-for-mild-moderate-alzheimer-s-disease-nirscure-03a-61442https://curecurrent.com/trials/predicting-pre-dementia-61443https://curecurrent.com/trials/a-master-protocol-studying-multiple-amyloid-targeting-therapies-in-healthy-participants-and-participants-with-alzheimer-61444https://curecurrent.com/trials/efficacy-and-safety-of-photobiomodulation-therapy-in-patients-with-mild-cognitive-impairment-and-mild-alzheimer-s-diseas-61445https://curecurrent.com/trials/a-study-to-evaluate-karxt-as-a-treatment-for-psychosis-associated-with-alzheimer-s-disease-adept-4-61446https://curecurrent.com/trials/cognition-and-affective-research-in-china-61447https://curecurrent.com/trials/a-study-of-donanemab-ly3002813-in-participants-with-early-cognitive-decline-trailblazer-alz-7-61448https://curecurrent.com/trials/brain-heath-service-for-prevention-of-ad-61449https://curecurrent.com/trials/neurostimulation-for-cognitive-enhancement-in-alzheimer-s-disease-61450https://curecurrent.com/trials/a-study-of-donanemab-ly3002813-in-participants-with-early-symptomatic-alzheimer-s-disease-trailblazer-alz-5-61451https://curecurrent.com/trials/promoting-goals-of-care-discussions-for-patients-with-memory-problems-and-their-caregivers-61452https://curecurrent.com/trials/the-lucinda-trial-leuprolide-plus-cholinesterase-inhibition-to-reduce-neurological-decline-in-alzheimer-s-61453https://curecurrent.com/trials/music-for-pain-and-dementia-61454https://curecurrent.com/trials/promoting-physical-activity-in-older-hispanic-latino-a-adults-61455https://curecurrent.com/trials/pet-imaging-tau-accumulation-in-ftld-and-atypical-alzheimer-s-using-18f-pi-2620-61456https://curecurrent.com/trials/effect-of-acetylcholinesterase-inhibitors-on-bone-metabolism-61457https://curecurrent.com/trials/a-retrospective-database-study-for-the-development-and-validation-of-algorithms-for-intracerebral-hemorrhage-and-seizure-61458https://curecurrent.com/trials/comparison-of-two-group-wellness-interventions-for-individuals-with-neurologic-conditions-and-their-support-persons-61459https://curecurrent.com/trials/microbiome-in-aging-of-gut-and-brain-61460https://curecurrent.com/trials/screening-study-to-determine-individuals-with-potential-trial-eligibility-for-alzheimer-s-disease-studies-61461https://curecurrent.com/trials/the-revitalize-study-in-older-adults-at-risk-for-alzheimer-s-disease-61462https://curecurrent.com/trials/study-of-aro-mapt-sc-in-healthy-participants-and-participants-with-early-alzheimer-s-disease-61463https://curecurrent.com/trials/study-of-safety-tolerability-pharmacodynamics-and-pharmacokinetics-of-nio752-in-early-alzheimer-s-disease-participants-61464https://curecurrent.com/trials/a-study-to-assess-the-safety-and-effects-of-abbv-1758-following-subcutaneous-or-intravenous-injections-in-participants-w-61465https://curecurrent.com/trials/decide-dyads-and-families-61466https://curecurrent.com/trials/falls-a-marker-of-preclinical-ad-61467https://curecurrent.com/trials/assessment-of-changes-in-autonomy-through-analysis-of-smartphone-usage-data-in-patients-with-alzheimer-s-disease-61468https://curecurrent.com/trials/pet-imaging-of-cyclooxygenases-in-neurodegenerative-brain-disease-61469https://curecurrent.com/trials/identifying-biomarkers-in-alzheimer-s-disease-61470https://curecurrent.com/trials/transcranial-random-noise-trns-for-bpsd-in-alzheimer-s-disease-a-double-blind-randomized-controlled-trial-61471https://curecurrent.com/trials/a-trial-to-evaluate-the-safety-and-efficacy-of-benfotiamine-in-patients-with-early-alzheimer-s-disease-benfoteam-61472https://curecurrent.com/trials/ecocapture-for-the-assessment-of-apathy-under-real-life-conditions-61473https://curecurrent.com/trials/efficacy-and-safety-of-gsk4527226-al101-in-participants-with-early-alzheimer-s-disease-61474https://curecurrent.com/trials/pulsed-electromagnetic-field-treatment-in-patients-with-alzheimer-s-disease-61475https://curecurrent.com/trials/advancing-ethical-goals-in-society-trial-61476https://curecurrent.com/trials/adaptango-performance-process-for-older-adults-community-rehabilitation-61477https://curecurrent.com/trials/pulsed-electromagnetic-field-treatment-with-dementia-patients-61478https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-karxt-karx-ec-for-cognitive-impairment-in-alzheimer-s-disease-mindset-2-61479https://curecurrent.com/trials/memory-improvement-through-nicotine-dosing-mind-study-61480https://curecurrent.com/trials/a-phase-3-study-to-evaluate-the-safety-and-efficacy-of-karxt-karx-ec-for-the-treatment-of-agitation-associated-with-alzh-61481https://curecurrent.com/trials/a-nutritional-and-pharmacological-intervention-for-body-brain-and-longevity-effects-nibble-61482https://curecurrent.com/trials/a-phase-3-study-to-evaluate-the-safety-and-efficacy-of-karxt-karx-ec-for-the-treatment-of-agitation-associated-with-alzh-61483https://curecurrent.com/trials/a-postmarketing-study-of-lecanemab-for-the-treatment-of-participants-with-alzheimer-s-disease-61484https://curecurrent.com/trials/personalized-brain-health-service-and-dementia-prevention-61485https://curecurrent.com/trials/dexmedetomidine-transdermal-systems-dmts-treatment-for-agitation-associated-with-dementia-of-the-alzheimer-s-type-61486https://curecurrent.com/trials/masupirdine-for-the-treatment-of-agitation-in-dementia-of-the-alzheimer-s-type-61487https://curecurrent.com/trials/the-brain-app-phase-2-sbir-61488https://curecurrent.com/trials/making-connections-thru-music-61489https://curecurrent.com/trials/an-insole-and-ankle-device-for-monitoring-cognitive-decline-in-individuals-at-risk-for-alzheimer-s-disease-and-or-alzhei-61490https://curecurrent.com/trials/phase-i-clinical-study-of-av-1959r-abeta-targeting-anti-alzheimer-s-vaccine-61491https://curecurrent.com/trials/how-video-game-therapy-affects-thinking-and-emotions-in-older-adults-with-cognitive-impairment-61492https://curecurrent.com/trials/the-role-of-the-locus-coeruleus-in-age-related-distractibility-61493https://curecurrent.com/trials/brainshuttle-ad-a-multiple-ascending-dose-study-to-investigate-the-safety-tolerability-pharmacokinetics-and-pharmacodyna-61494https://curecurrent.com/trials/water-based-activity-to-enhance-recall-in-veterans-a-randomized-clinical-trial-61495https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-tolerability-of-aln-app-in-patients-with-eoad-61496https://curecurrent.com/trials/mhealth-intervention-for-pain-self-management-61497https://curecurrent.com/trials/a-study-to-evaluate-aln-5288-in-patients-with-alzheimer-s-disease-61498https://curecurrent.com/trials/implementation-of-aip-services-for-older-adults-with-ad-61499https://curecurrent.com/trials/study-to-understand-novel-biomarkers-in-researching-dementia-61500https://curecurrent.com/trials/adaptation-of-the-mini-mental-state-examination-mmse-for-the-reunion-island-population-61501https://curecurrent.com/trials/randomized-controlld-trial-of-dementia-education-resources-for-action-61502https://curecurrent.com/trials/fractional-co-laser-for-primary-cutaneous-amyloidosis-61503https://curecurrent.com/trials/a-study-of-trontinemab-in-cognitively-unimpaired-individuals-at-risk-for-progression-to-symptomatic-alzheimer-s-disease-61504https://curecurrent.com/trials/aging-brain-care-virtual-program-61505https://curecurrent.com/trials/multimodal-biomarkers-in-individual-with-cognitive-impairment-and-dementia-61506https://curecurrent.com/trials/digitally-enhanced-decentralized-multi-omics-observational-cohort-61507https://curecurrent.com/trials/study-of-repetitive-behaviors-in-alzheimer-s-disease-61508https://curecurrent.com/trials/the-ketogenic-diet-for-alzheimer-s-disease-61509https://curecurrent.com/trials/reverse-long-covid-19-with-baricitinib-study-61510https://curecurrent.com/trials/glutathione-brain-metabolism-and-inflammation-in-alzheimer-s-disease-61511https://curecurrent.com/trials/cerebrospinal-fluid-mitochondrial-biomarkers-in-ischemic-stroke-and-alzheimer-disease-61512https://curecurrent.com/trials/the-wandering-nerve-gateway-to-boost-alzheimer-s-disease-related-cognitive-performance-61513https://curecurrent.com/trials/effect-of-hydralazine-on-alzheimer-s-disease-61514https://curecurrent.com/trials/a-pivotal-study-of-sensory-stimulation-in-alzheimer-s-disease-hope-study-61515https://curecurrent.com/trials/piromelatine-20-mg-in-participants-with-mild-dementia-due-to-alzheimer-s-disease-61516https://curecurrent.com/trials/a-study-of-psychedelics-in-healthy-older-adults-with-low-well-being-61517https://curecurrent.com/trials/a-study-to-investigate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-ro7812653-in-participants-with-e-61518https://curecurrent.com/trials/exploring-the-utility-of-18f-3f4ap-for-demyelination-imaging-61519https://curecurrent.com/trials/18f-ft8-pet-imaging-in-immunoglobulin-light-chain-amyloidosis-61520https://curecurrent.com/trials/alzheimer-s-disease-genetics-study-61521https://curecurrent.com/trials/evaluating-novel-healthcare-approaches-to-nurturing-and-caring-for-hospitalized-elders-61522https://curecurrent.com/trials/therapeutic-diets-in-alzheimer-s-disease-61523https://curecurrent.com/trials/18f-nidf-pet-imaging-in-tau-related-diseases-61524https://curecurrent.com/trials/head-to-head-harmonization-of-tau-tracers-in-alzheimer-s-disease-61525https://curecurrent.com/trials/pan-amyloid-pet-ct-in-various-amyloid-related-disease-61526https://curecurrent.com/trials/electroconvulsive-therapy-for-treatment-of-alzheimer-s-disease-61527https://curecurrent.com/trials/alzheimer-s-tau-platform-regimen-a-aadvac1-61528https://curecurrent.com/trials/beta-amyloid-pet-ct-in-various-a-related-disease-61529https://curecurrent.com/trials/alzheimer-s-tau-platform-master-protocol-61530https://curecurrent.com/trials/neurophysiological-benefits-of-live-music-for-early-alzheimer-s-patients-and-their-caregivers-61531https://curecurrent.com/trials/psilocybin-for-depression-in-people-with-mild-cognitive-impairment-or-early-alzheimer-s-disease-61532https://curecurrent.com/trials/tau-pet-ct-imaging-in-the-mismatch-prospective-cohort-study-mpc-tau-61533https://curecurrent.com/trials/an-open-label-dose-escalation-study-of-vy1706-in-participants-with-early-alzheimer-s-disease-61534https://curecurrent.com/trials/large-coil-parietal-repetitive-transcranial-magnetic-stimulation-rtms-for-alzheimer-disease-ad-61535https://curecurrent.com/trials/a-study-to-assess-efficacy-and-safety-of-karxt-for-the-treatment-of-psychosis-associated-with-alzheimer-s-disease-adept-61536https://curecurrent.com/trials/otc-hearing-aid-and-mci-61537https://curecurrent.com/trials/global-blood-brain-barrier-disruption-and-post-stroke-cognitive-decline-61538https://curecurrent.com/trials/remotely-supervised-neuromodulation-in-ppa-61539https://curecurrent.com/trials/a-study-to-evaluate-mivelsiran-in-adult-participants-with-early-stage-down-syndrome-associated-alzheimer-s-disease-ds-ad-61540https://curecurrent.com/trials/a-study-of-mk-2214-in-adults-with-mild-cognitive-impairment-or-mild-to-moderate-alzheimer-s-disease-mk-2214-002-61541https://curecurrent.com/trials/adrc-clinical-cohort-alzheimer-s-disease-61542https://curecurrent.com/trials/longitudinal-profiling-of-plasma-derived-glial-extracellular-vesicles-in-alzheimer-s-disease-61543https://curecurrent.com/trials/comfortage-ad-prevention-strategies-61544https://curecurrent.com/trials/alzevit-nationwide-digital-apoe-4-cohort-for-early-alzheimer-s-disease-prevention-and-trial-readiness-61545https://curecurrent.com/trials/adaptation-of-the-uniform-data-set-for-telematic-administration-61546https://curecurrent.com/trials/neurodegenerative-diseases-progression-markers-markers-ndd-61547https://curecurrent.com/trials/a-study-of-donanemab-rg6289-or-the-combination-of-donanemab-and-rg6289-in-presenilin-1-psen1-e280a-mutation-carriers-for-61548https://curecurrent.com/trials/life-s-end-benefits-of-cannabidiol-and-tetrahydrocannabinol-61549https://curecurrent.com/trials/speech-based-artificial-intelligence-for-detection-of-dementia-in-danish-patients-detectai-61550https://curecurrent.com/trials/supporting-our-caregivers-in-adrd-learning-social-61551https://curecurrent.com/trials/closed-loop-brain-stimulation-as-a-potential-intervention-for-cognitive-decline-61552https://curecurrent.com/trials/autonomic-involvement-in-patient-with-cognitive-decline-61553https://curecurrent.com/trials/probiotic-milk-drink-for-gut-and-brain-health-in-older-adults-and-caregivers-61554https://curecurrent.com/trials/efficacy-and-safety-of-nvp-nk4146-in-patients-with-mild-cognitive-impairment-mci-due-to-alzheimer-s-disease-61555https://curecurrent.com/trials/contributions-of-mtbi-to-neurodegeneration-due-to-chronic-traumatic-encephalopathy-cte-and-alzheimer-s-disease-ad-61556https://curecurrent.com/trials/terazosin-and-metabolic-engagement-in-alzheimer-s-disease-61557https://curecurrent.com/trials/biofluid-research-on-age-related-or-inherited-neurodegeneration-61558https://curecurrent.com/trials/cholinergic-deep-brain-stimulation-for-alzheimer-s-disease-61559https://curecurrent.com/trials/dyadic-life-review-intervention-for-older-patients-with-advanced-cancer-and-alzheimer-s-disease-and-related-dementias-an-61560https://curecurrent.com/trials/transforming-maternal-mental-health-care-61561https://curecurrent.com/trials/repurposing-a-combination-antiretroviral-drug-therapy-to-target-retrotransposons-and-treat-early-alzheimer-s-disease-61562https://curecurrent.com/trials/efficacy-and-safety-of-transcranial-magnetic-stimulation-in-treatment-of-alzheimer-s-disease-61563https://curecurrent.com/trials/a-study-of-ono-2020-in-participants-with-mild-to-moderate-alzheimer-s-disease-61564https://curecurrent.com/trials/a-study-of-amdx-2011p-in-participants-with-alzheimer-s-disease-61565https://curecurrent.com/trials/effectiveness-of-a-smartphone-app-primi-to-promote-healthy-diet-and-physical-activity-after-pregnancy-in-migrant-women-61566https://curecurrent.com/trials/a-28-day-study-of-gal-101-in-participants-with-mild-to-moderate-alzheimer-s-disease-61567https://curecurrent.com/trials/a-study-of-donanemab-ly3002813-in-participants-with-early-alzheimer-s-disease-trailblazer-alz-2-61568https://curecurrent.com/trials/a-clinical-study-of-mk-2214-in-people-with-early-alzheimer-s-disease-mk-2214-004-61569https://curecurrent.com/trials/study-of-intracerebroventricular-injections-of-autologous-adipose-derived-stem-cells-rb-adscs-in-participants-with-mild-61570https://curecurrent.com/trials/be-smart-bariatric-patient-empowerment-in-the-preparation-and-follow-up-of-bariatric-surgery-using-the-smartvisit-app-be-61571https://curecurrent.com/trials/screening-for-memory-studies-61572https://curecurrent.com/trials/18f-aci-19626-pet-in-tdp-43-proteinopathies-61573https://curecurrent.com/trials/repeat-intracerebroventricular-injections-of-rb-adsc-in-subjects-previously-treated-in-rbi-protocol-rb-adsc-02-61574https://curecurrent.com/trials/veech-ketone-ester-to-support-brain-energy-in-mild-cognitive-impairment-and-early-alzheimer-s-disease-61575https://curecurrent.com/trials/recombinant-human-serum-albumin-in-the-treatment-of-mild-to-moderate-ad-alzheimer-s-disease-exploratory-clinical-trial-61576https://curecurrent.com/trials/the-role-of-methanogens-in-the-progression-of-parkinson-s-disease-and-related-neurological-conditions-61577https://curecurrent.com/trials/preventing-alzheimer-s-with-cognitive-training-61578https://curecurrent.com/trials/donanemab-ly3002813-trial-in-chinese-participants-with-cognitively-unimpaired-preclinical-alzheimer-s-disease-61579https://curecurrent.com/trials/acupressure-as-long-term-intervention-to-slow-the-progression-of-early-mild-alzheimer-s-disease-61580https://curecurrent.com/trials/robotic-enabled-microsurgical-intervention-for-neurodegenerative-disease-61581https://curecurrent.com/trials/a-first-in-human-study-of-ly3954068-in-participants-with-early-symptomatic-alzheimer-s-disease-61582https://curecurrent.com/trials/investigation-of-inflammation-using-c-11-cs1p1-61583https://curecurrent.com/trials/a-postmarketing-study-of-leqembi-in-united-kingdom-uk-participants-with-alzheimer-s-disease-ad-61584https://curecurrent.com/trials/effects-and-mechanisms-of-temporal-interference-brain-stimulation-on-memory-function-in-preclinical-alzheimer-s-disease-61585https://curecurrent.com/trials/av-1980r-tau-vaccine-in-preclinical-alzheimer-s-disease-taurus-1980-61586https://curecurrent.com/trials/clinical-trial-of-solanezumab-for-older-individuals-who-may-be-at-risk-for-memory-loss-61587https://curecurrent.com/trials/efficacy-of-rgn600-in-patients-with-mild-to-moderate-alzheimer-s-disease-61588https://curecurrent.com/trials/early-diagnosis-of-scd-based-on-radiogenomics-61589https://curecurrent.com/trials/physical-activity-alzheimer-s-disease-and-cognition-relative-to-apoe-genotype-61590https://curecurrent.com/trials/causal-effect-of-coenzyme-q10-nutrition-and-cognitive-dysfunction-in-the-metabolic-storm-hyperglycemia-and-sarcopenia-an-61591https://curecurrent.com/trials/caring-recharge-project-for-caregivers-of-individuals-with-alzheimer-s-disease-61592https://curecurrent.com/trials/vica-a-virtual-care-assistant-for-dementia-caregivers-61593https://curecurrent.com/trials/fisetin-in-mild-alzheimer-s-disease-61594https://curecurrent.com/trials/n-ad-orally-administered-nicotinamide-riboside-over-two-years-as-a-potential-disease-modifying-treatment-for-alzheimer-s-61595https://curecurrent.com/trials/effect-of-equol-supplementation-on-arterial-stiffness-and-cognition-in-healthy-volunteers-61596https://curecurrent.com/trials/central-auditory-processing-modulation-underlying-anxiety-reduction-using-clinically-designed-improvisatory-music-61597https://curecurrent.com/trials/a-primary-care-based-psychosocial-intervention-to-improve-cognitive-depression-outcomes-in-older-adults-with-mci-early-s-61598https://curecurrent.com/trials/mechanisms-of-neuronal-resilience-in-alzheimer-s-disease-and-its-focal-variants-a-pet-mr-study-61599https://curecurrent.com/trials/a-study-to-evaluate-the-safety-pharmacokinetics-and-pharmacodynamics-of-dnl921-in-healthy-participants-and-participants-61600https://curecurrent.com/trials/enhancing-outcomes-in-cognitive-impairment-through-use-of-home-sleep-apnea-testing-61601https://curecurrent.com/trials/presence-of-anti-rach-antibodies-and-neurocognitive-disorder-in-myasthenic-or-alzheimers-s-patients-61602https://curecurrent.com/trials/low-intensity-focused-ultrasound-for-mild-cognitive-impairment-and-mild-alzheimer-s-disease-61603https://curecurrent.com/trials/an-open-label-long-term-safety-study-of-buntanetap-in-participants-with-ad-61604https://curecurrent.com/trials/the-effect-of-sequential-therapy-on-alzheimer-s-disease-61605https://curecurrent.com/trials/nad-augmentation-to-prevent-or-reverse-alzheimer-s-disease-in-people-with-down-syndrome-61606https://curecurrent.com/trials/a-mobile-informatics-solution-to-assist-caregivers-in-care-coordination-and-monitoring-social-engagement-61607https://curecurrent.com/trials/development-of-measures-to-screen-for-financial-hardship-in-alzheimer-s-disease-and-dementia-61608https://curecurrent.com/trials/feasibility-acceptability-of-app-based-cognitive-behavioral-therapy-for-postpartum-depression-prevention-61609https://curecurrent.com/trials/study-of-the-brain-s-natural-cleaning-system-in-potential-organ-donors-61610https://curecurrent.com/trials/a-research-study-looking-at-the-effect-of-semaglutide-on-the-immune-system-and-other-biological-processes-in-people-with-61611https://curecurrent.com/trials/alzheimer-s-plasma-extension-61612https://curecurrent.com/trials/clinical-study-to-evaluate-the-efficacy-and-safety-of-huperzine-a-controlled-release-tablets-in-patients-with-mild-to-mo-61613https://curecurrent.com/trials/i-care-rural-pilot-intervention-for-rural-dwelling-dementia-caregivers-61614https://curecurrent.com/trials/efficacy-of-gamma-auditory-stimulation-for-cognitive-decline-in-older-adults-study-1-61615https://curecurrent.com/trials/a-study-to-evaluate-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-e2511-in-participants-with-early-alzhei-61616https://curecurrent.com/trials/establishing-normal-cognitive-test-scores-for-adults-using-a-voice-enabled-digital-testing-platform-across-the-lifespan-61617https://curecurrent.com/trials/senicapoc-in-alzheimer-s-disease-61618https://curecurrent.com/trials/evaluate-the-concordance-between-pet-imaging-of-18f-apn-1607-injection-and-postmortem-brain-tissue-tau-pathology-in-indi-61619https://curecurrent.com/trials/i-care-2-mobile-telehealth-to-reduce-alzheimer-s-related-symptoms-in-hispanic-individuals-61620https://curecurrent.com/trials/a-study-to-assess-efficacy-and-safety-of-karxt-for-the-treatment-of-psychosis-associated-with-alzheimer-s-disease-adept-61621https://curecurrent.com/trials/using-the-ehr-to-advance-genomic-medicine-across-a-diverse-health-system-61622https://curecurrent.com/trials/behavioral-change-following-alzheimer-s-disease-ad-biomarker-disclosure-61623https://curecurrent.com/trials/dementia-care-partner-hospital-assessment-tool-61624https://curecurrent.com/trials/a-clinical-study-evaluating-the-diagnostic-performance-and-safety-of-pet-for-the-deposition-of-a-plaques-in-the-brain-of-61625https://curecurrent.com/trials/sage-leaf-2-an-online-program-to-reduce-dementia-caregiver-burden-61626https://curecurrent.com/trials/safety-and-efficacy-of-exv-802-and-exv-801-in-the-treatment-of-agitation-in-alzheimer-s-disease-dementia-61627https://curecurrent.com/trials/wisconsin-brain-donor-program-61628https://curecurrent.com/trials/vanderbilt-memory-and-aging-project-61629https://curecurrent.com/trials/memory-deterioration-in-alzheimer-disease-61630https://curecurrent.com/trials/multimodal-assesment-of-alzheimer-patients-61631https://curecurrent.com/trials/use-of-a-mobile-brain-body-imaging-approach-to-evaluate-the-effects-of-rhythmic-auditory-stimulation-on-gait-and-brain-f-61632https://curecurrent.com/trials/a-study-to-assess-the-efficacy-and-safety-of-axs-05-in-subjects-with-alzheimer-s-disease-agitation-61633https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-biomarker-effects-of-ro7269162-in-participants-at-risk-for-or-at-the-prodromal-stage-61634https://curecurrent.com/trials/cycle-ad-cycling-to-cease-or-limit-the-effects-of-alzheimer-s-disease-61635https://curecurrent.com/trials/early-age-related-hearing-loss-investigation-earhli-61636https://curecurrent.com/trials/daily-goal-setting-to-increase-everyday-physical-activity-and-promote-cognitive-health-in-midlife-61637https://curecurrent.com/trials/uab-alzheimer-s-disease-center-core-cohort-imaging-substudy-61638https://curecurrent.com/trials/uab-alzheimer-s-disease-center-core-cohort-tau-imaging-substudy-61639https://curecurrent.com/trials/to-evaluate-the-long-term-safety-and-tolerability-of-acoramidis-in-participants-with-newly-diagnosed-attr-cm-act-early-o-61640https://curecurrent.com/trials/multisensory-40-hz-stimulation-for-alzheimer-s-disease-61641https://curecurrent.com/trials/compass-for-care-a-theory-driven-mobile-solution-to-promote-well-being-among-caregivers-of-individuals-with-adrd-61642https://curecurrent.com/trials/lived-experience-narratives-in-dementia-61643https://curecurrent.com/trials/alzheimer-s-disease-research-center-adrc-pet-component-study-61644https://curecurrent.com/trials/aldh2-genetic-testing-in-east-asian-community-61645https://curecurrent.com/trials/metformin-in-alzheimer-s-dementia-prevention-61646https://curecurrent.com/trials/a-study-to-assess-the-feasibility-of-indivi-mobile-application-in-monitoring-cognitive-performance-in-aging-population-61647https://curecurrent.com/trials/the-singapore-geriatric-intervention-study-to-reduce-cognitive-decline-and-physical-frailty-singer-study-61648https://curecurrent.com/trials/multisensory-environment-based-occupational-therapy-for-alzheimer-s-patients-61649https://curecurrent.com/trials/safety-of-nrtis-for-alzheimer-s-therapeutic-advancement-in-singapore-study-61650https://curecurrent.com/trials/sociodemographic-factors-and-criminal-behaviour-preceding-neurodegenerative-disease-retrospective-register-study-61651https://curecurrent.com/trials/neural-mechanisms-of-clinically-designed-improvisatory-music-for-alzheimer-s-disease-61652https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-ct1812-in-early-alzheimer-s-disease-61653https://curecurrent.com/trials/a-first-in-human-study-of-ibc-ab002-in-persons-with-early-alzheimer-s-disease-ad-61654https://curecurrent.com/trials/communityrx-dementia-61655https://curecurrent.com/trials/an-open-label-study-of-ml-007c-ma-in-adults-with-alzheimer-s-disease-psychosis-61656https://curecurrent.com/trials/nuestro-sueno-cultural-adaptation-of-a-couples-intervention-to-improve-pap-adherence-and-sleep-health-among-latino-coupl-61657https://curecurrent.com/trials/neuclare-device-for-temporary-improvement-of-executive-function-in-patients-with-mild-cognitive-impairment-and-prodromal-61658https://curecurrent.com/trials/the-effects-of-successful-osa-treatment-on-memory-and-ad-biomarkers-in-older-adults-study-61659https://curecurrent.com/trials/align-aligning-medications-with-what-matters-most-demonstration-61660https://curecurrent.com/trials/evaluating-the-effectiveness-of-the-health-app-recommendation-tool-61661https://curecurrent.com/trials/study-to-evaluate-the-effect-of-ht-4253-for-the-prevention-of-alzheimer-s-disease-in-apoe4-carriers-61662https://curecurrent.com/trials/acp-204-in-adults-with-alzheimer-s-disease-psychosis-open-label-extension-study-61663https://curecurrent.com/trials/innovative-cognitive-impairment-case-finding-and-engagement-for-diverse-participation-in-alzheimer-s-disease-care-treatm-61664https://curecurrent.com/trials/acoramidis-transthyretin-amyloidosis-prevention-trial-in-the-young-act-early-study-in-asymptomatic-carriers-of-a-pathoge-61665https://curecurrent.com/trials/gamma-sensory-flicker-for-parkinson-s-disease-patients-with-freezing-of-gait-61666https://curecurrent.com/trials/autoimmune-features-of-neurodegenerative-disorders-61667https://curecurrent.com/trials/reducing-risk-of-dementia-through-deprescribing-61668https://curecurrent.com/trials/safety-tolerability-and-biomarker-based-efficacy-of-npi-001-at-001-in-subjects-with-mci-or-alzheimer-s-disease-ad-61669https://curecurrent.com/trials/assessing-treatment-with-high-phenolic-evoo-supplements-for-neurovascular-activity-61670https://curecurrent.com/trials/effects-of-musical-intervention-by-a-therapist-imt-on-falling-asleep-and-behavioral-regulation-in-a-secure-care-unit-scu-61671https://curecurrent.com/trials/adapting-rdad-for-ds-61672https://curecurrent.com/trials/telerehabilitation-in-alzheimer-s-disease-61673https://curecurrent.com/trials/sleep-interventions-and-neurocognitive-outcomes-61674https://curecurrent.com/trials/brain-energy-for-amyloid-transformation-in-alzheimer-s-disease-study-61675https://curecurrent.com/trials/digital-detection-of-dementia-d-cubed-studies-d3-61676https://curecurrent.com/trials/effectiveness-of-strength-based-intervention-for-elderly-with-dementia-living-in-the-community-61677https://curecurrent.com/trials/validation-of-a-remediation-method-for-memory-impairments-through-motor-encoding-in-patients-with-alzheimer-s-disease-61678https://curecurrent.com/trials/an-observational-study-on-lecanemab-treatment-for-early-alzheimer-s-disease-61679https://curecurrent.com/trials/cannabidiol-medication-intervention-trial-61680https://curecurrent.com/trials/deprescribing-in-patients-living-with-dementia-with-caregiver-and-provider-nudges-61681https://curecurrent.com/trials/electroconvulsive-therapy-ect-for-agitation-in-dementia-ad-61682https://curecurrent.com/trials/university-of-central-florida-music-study-61683https://curecurrent.com/trials/using-a-wireless-controller-to-deliver-a-lighting-intervention-to-persons-with-dementia-61684https://curecurrent.com/trials/impact-of-covid-19-vaccines-on-cerebrovascular-health-61685https://curecurrent.com/trials/technology-and-family-thriving-study-61686https://curecurrent.com/trials/cardiac-magnetic-resonance-and-echocardiography-study-with-acoramidis-61687https://curecurrent.com/trials/remote-monitoring-in-progressive-supranuclear-palsy-psp-61688https://curecurrent.com/trials/utilizing-palliative-leaders-in-facilities-to-transform-care-for-alzheimer-s-disease-61689https://curecurrent.com/trials/longitudinal-early-onset-alzheimer-s-disease-study-protocol-61690https://curecurrent.com/trials/levetiracetam-for-persons-at-risk-for-alzheimer-s-disease-61691https://curecurrent.com/trials/digital-solutions-for-predicting-the-biological-mechanisms-of-alzheimer-s-disease-through-the-analysis-of-risk-factors-61692https://curecurrent.com/trials/pensa-extended-follow-up-of-a-multimodal-lifestyle-intervention-to-prevent-cognitive-decline-in-apoe-4-carriers-61693https://curecurrent.com/trials/phase-1-study-of-olx-07010-in-healthy-adult-and-elderly-participants-61694https://curecurrent.com/trials/a-study-of-potential-disease-modifying-treatments-in-individuals-at-risk-for-or-with-a-type-of-early-onset-ad-caused-by-61695https://curecurrent.com/trials/dominantly-inherited-alzheimer-network-trial-an-opportunity-to-prevent-dementia-a-study-of-potential-disease-modifying-t-61696https://curecurrent.com/trials/commets-combination-mci-metabolic-syndrome-61697https://curecurrent.com/trials/ozanimod-in-patients-with-alzheimer-s-disease-61698https://curecurrent.com/trials/community-based-brain-health-program-to-address-dementia-risk-61699https://curecurrent.com/trials/a-study-of-a-potential-disease-modifying-treatment-in-individuals-at-risk-for-or-with-a-type-of-early-onset-ad-caused-by-61700https://curecurrent.com/trials/dominantly-inherited-alzheimer-network-trial-an-opportunity-to-prevent-dementia-a-study-of-potential-disease-modifying-t-61701https://curecurrent.com/trials/effect-and-safety-of-non-invasive-electrical-stimulation-in-alzheimer-s-disease-61702https://curecurrent.com/trials/dian-tu-amyloid-removal-trial-art-in-dominantly-inherited-alzheimer-s-disease-61703https://curecurrent.com/trials/michigan-healthy-mom-mi-mom-pregnancy-improvement-web-application-trial-61704https://curecurrent.com/trials/a-study-to-test-the-efficacy-safety-and-tolerability-of-bepranemab-ucb0107-in-patients-with-mild-cognitive-impairment-or-61705https://curecurrent.com/trials/an-evaluation-of-treatments-for-sustained-clinical-response-18-months-in-symptomatic-alzheimer-s-disease-61706https://curecurrent.com/trials/impact-of-nilotinib-on-safety-biomarkers-and-clinical-outcomes-in-mild-to-moderate-alzheimer-s-disease-61707https://curecurrent.com/trials/digital-dementia-registry-bavaria-digidem-bayern-a-multicentre-prospective-longitudinal-register-study-including-people-61708https://curecurrent.com/trials/impact-of-microglial-activation-on-synaptic-density-in-alzheimer-s-disease-61709https://curecurrent.com/trials/optical-coherence-tomography-in-neurological-practice-utility-and-applicability-across-neurological-diseases-oct-in-n-61710https://curecurrent.com/trials/pilot-study-on-the-feasibility-of-using-smartphone-data-as-a-diagnostic-marker-for-alzheimer-s-disease-61711https://curecurrent.com/trials/national-bank-alzheimer-61712https://curecurrent.com/trials/efficacy-of-lymphatic-venous-anastomosis-plus-donepezil-versus-donepezil-alone-for-alzheimer-s-disease-61713https://curecurrent.com/trials/therapeutic-evaluation-of-low-dose-il-2-based-immunomodulatory-approach-in-patients-with-early-ad-61714https://curecurrent.com/trials/impact-of-intensive-treatment-of-sbp-on-brain-perfusion-amyloid-and-tau-ipat-study-61715https://curecurrent.com/trials/emergency-preparedness-for-caregivers-of-persons-with-dementia-disaster-prepwise-61716https://curecurrent.com/trials/blood-tests-for-alzheimer-s-disease-can-plasma-biomarkers-diagnose-and-predict-disease-progression-61717https://curecurrent.com/trials/transcranial-magnetic-stimulation-for-alzheimer-s-disease-treatment-61718https://curecurrent.com/trials/door-through-door-companion-rideshare-technology-for-individuals-with-alzheimer-s-disease-and-related-dementias-ad-adrd-61719https://curecurrent.com/trials/a-study-of-a-mobile-phone-application-measuring-the-eyes-before-and-after-medication-61720https://curecurrent.com/trials/brain-safe-consumer-intervention-to-reduce-exposure-to-drugs-linked-to-alzheimer-s-disease-61721https://curecurrent.com/trials/fitmi-ad-home-therapy-for-individuals-with-mci-or-mild-dementia-due-to-alzheimer-s-disease-61722https://curecurrent.com/trials/pathways-relating-amnestic-mci-to-a-mild-traumatic-brain-injury-history-61723https://curecurrent.com/trials/improvement-of-sleep-disorders-in-patients-with-alzheimer-s-disease-after-sunlight-exposure-therapy-61724https://curecurrent.com/trials/improving-access-to-care-for-veterans-with-memory-loss-61725https://curecurrent.com/trials/biomarkers-of-the-locus-coeruleus-nucleus-links-with-early-tau-pathology-cognition-and-alzheimer-s-disease-risk-61726https://curecurrent.com/trials/alsenlite-senolytics-for-alzheimer-s-disease-61727https://curecurrent.com/trials/goal-setting-to-promote-physical-activity-adherence-in-midlife-adults-61728https://curecurrent.com/trials/molecular-and-structural-imaging-in-alzheimer-s-disease-a-longitudinal-study-61729https://curecurrent.com/trials/german-registry-of-alzheimer-s-disease-treated-with-transcranial-pulse-stimulation-61730https://curecurrent.com/trials/home-based-brain-stimulation-for-motoric-cognitive-risk-syndrome-61731https://curecurrent.com/trials/the-caffeine-postoperative-delirium-and-change-in-outcomes-after-surgery-capachinos-2-study-61732https://curecurrent.com/trials/investigating-the-effectiveness-of-personalized-optimal-gamma-auditory-frequency-stimulation-intervention-on-cognitive-f-61733https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-ttyp01-tablets-in-early-symptomatic-alzheimer-s-disease-61734https://curecurrent.com/trials/detection-of-amyloid-deposits-in-the-wrist-by-mri-with-mapping-and-high-resolution-sequences-in-systemic-amyloidosis-amy-61735https://curecurrent.com/trials/robotic-enabled-microsurgical-intervention-for-neurodegenerative-disease-eu-61736https://curecurrent.com/trials/pilot-testing-dementia-enhanced-training-and-tool-for-home-hospice-clinicians-61737https://curecurrent.com/trials/online-insomnia-intervention-to-reduce-alcohol-use-61738https://curecurrent.com/trials/effects-of-electrical-stimulation-on-verbal-learning-in-typical-and-atypical-alzheimer-s-disease-61739https://curecurrent.com/trials/a-feasiblity-study-of-green-activity-program-for-people-living-with-memory-challenges-61740https://curecurrent.com/trials/interventions-for-patients-with-alzheimer-s-disease-and-dysphagia-61741https://curecurrent.com/trials/brain-health-in-midlife-61742https://curecurrent.com/trials/development-of-a-home-test-for-measuring-blood-p-tau217-in-alzheimer-s-disease-using-the-tasso-lancet-device-61743https://curecurrent.com/trials/individual-closed-loop-neuromodulation-therapy-for-alzheimer-s-disease-61744https://curecurrent.com/trials/sleep-trial-to-prevent-alzheimer-s-disease-61745https://curecurrent.com/trials/self-consciousness-in-dementia-61746https://curecurrent.com/trials/dora-and-lp-in-alzheimer-s-disease-biomarkers-61747https://curecurrent.com/trials/moving-yourself-in-space-and-time-mystic-61748https://curecurrent.com/trials/pmn310-in-patients-with-early-alzheimer-s-disease-precise-ad-61749https://curecurrent.com/trials/trial-of-cort108297-to-attenuate-the-effects-of-acute-stress-in-the-allocortex-cort-x-61750https://curecurrent.com/trials/georgia-memory-net-anti-amyloid-monoclonal-antibody-registry-61751https://curecurrent.com/trials/study-to-assess-safety-and-efficacy-of-pri-002-in-patients-with-mci-to-mild-dementia-due-to-alzheimer-s-disease-ad-61752https://curecurrent.com/trials/a-study-to-assess-the-effects-of-aci-24-060-in-alzheimer-s-disease-and-in-down-syndrome-abate-study-61753https://curecurrent.com/trials/leading-dementia-end-of-life-planning-conversations-61754https://curecurrent.com/trials/conectando-corazones-intervention-in-family-caregivers-of-an-older-adult-with-dementia-61755https://curecurrent.com/trials/a-clinical-trial-of-aav2-bdnf-gene-therapy-in-early-alzheimer-s-disease-and-mild-cognitive-impairment-61756https://curecurrent.com/trials/low-dose-radiotherapy-for-alzheimer-s-disease-61757https://curecurrent.com/trials/network-guided-individualized-tms-for-bpsd-in-alzheimer-s-disease-a-double-blind-randomized-controlled-trial-61758https://curecurrent.com/trials/wecaretofeeddysphagia-to-reduce-care-partner-burden-full-scale-rct-61759https://curecurrent.com/trials/a-study-of-gsm-779690t-in-healthy-adult-participants-61760https://curecurrent.com/trials/a-study-to-assess-thn391-in-subjects-with-alzheimer-s-disease-61761https://curecurrent.com/trials/sad-study-of-cgb3002-in-healthy-participants-61762https://curecurrent.com/trials/exploratory-open-label-study-for-development-of-a-method-to-detect-dendritic-cells-61763https://curecurrent.com/trials/neurocare-community-project-a-community-based-prospective-observational-study-for-early-alzheimer-s-detection-in-hk-61764https://curecurrent.com/trials/designing-care-management-for-hospice-transitions-for-persons-living-with-advanced-dementia-61765https://curecurrent.com/trials/apolipoprotein-e-apoe-genotype-effects-on-triglycerides-and-blood-flow-in-the-human-brain-61766https://curecurrent.com/trials/smartphone-app-for-adolescents-with-idiopathic-scoliosis-61767https://curecurrent.com/trials/evaluation-system-for-lecanemab-efficacy-using-gold-electrode-ecl-to-monitor-alzheimer-s-biomarkers-61768https://curecurrent.com/trials/epidemiology-and-biomarker-study-in-alzheimer-s-disease-61769https://curecurrent.com/trials/brain-wave-informed-non-invasive-brain-stimulation-improving-neural-networks-of-working-memory-in-dementia-a-proof-of-co-61770https://curecurrent.com/trials/a-study-of-donanemab-ly3002813-in-participants-who-completed-study-aacm-trailblazer-alz-3-ext-61771https://curecurrent.com/trials/a-research-study-investigating-semaglutide-in-people-with-early-alzheimer-s-disease-evoke-61772https://curecurrent.com/trials/investigation-of-alzheimer-s-predictors-in-subjective-memory-complainers-extension-study-61773https://curecurrent.com/trials/time-in-bed-restriction-in-older-adults-with-sleep-difficulties-with-and-without-risk-for-alzheimer-s-disease-61774https://curecurrent.com/trials/the-care-for-america-s-aging-study-61775https://curecurrent.com/trials/longitudinal-imaging-of-microglial-activation-in-different-clinical-variants-of-alzheimer-s-disease-61776https://curecurrent.com/trials/the-brain-health-study-a-pragmatic-patient-centered-trial-61777https://curecurrent.com/trials/financial-counseling-for-dementia-family-caregivers-in-early-and-middle-adulthood-61778https://curecurrent.com/trials/the-bridge-towards-implementation-of-blood-based-biomarkers-to-enable-early-and-accurate-diagnosis-of-alzheimer-s-diseas-61779https://curecurrent.com/trials/stimulation-to-improve-memory-61780https://curecurrent.com/trials/tricaprilin-phase-3-alter-ad-alternative-alzheimer-disease-study-61781https://curecurrent.com/trials/sirtuin-nad-activator-in-alzheimer-s-disease-61782https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-mk-1167-in-participants-with-alzheimer-s-disease-dementia-mk-1167-008-61783https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-dnl628-in-participants-with-early-a-61784https://curecurrent.com/trials/fasting-enhance-pilot-study-61785https://curecurrent.com/trials/effects-of-nicotinamide-riboside-on-bioenergetics-and-oxidative-stress-in-mild-cognitive-impairment-alzheimer-s-dementia-61786https://curecurrent.com/trials/leucettinib-21-first-in-human-phase-1-in-healthy-volunteers-and-subjects-with-down-syndrome-and-alzheimer-s-disease-61787https://curecurrent.com/trials/clinical-risk-score-prediction-for-risk-of-dementia-among-late-life-population-with-depression-61788https://curecurrent.com/trials/a-study-to-learn-about-the-safety-of-diranersen-biib080-injections-and-whether-they-can-improve-symptoms-of-participants-61789https://curecurrent.com/trials/a-study-to-evaluate-safety-and-efficacy-of-karxt-karx-ec-as-a-treatment-for-psychosis-associated-with-alzheimer-s-diseas-61790https://curecurrent.com/trials/neurodegenerative-alzheimer-s-disease-and-amyotrophic-lateral-sclerosis-nadals-basket-trial-61791https://curecurrent.com/trials/allopregnanolone-regenerative-therapeutic-for-mild-alzheimer-s-disease-61792https://curecurrent.com/trials/effects-of-x-box-kinect-360-in-alzheimer-s-disease-61793https://curecurrent.com/trials/home-based-closed-loop-auditory-stimulation-to-enhance-slow-wave-activity-in-mci-due-to-alzheimer-s-disease-a-proof-of-c-61794https://curecurrent.com/trials/premorbid-personality-profile-of-patients-with-cognitive-and-behavioral-disorders-61795https://curecurrent.com/trials/a-study-of-xpro1595-in-patients-with-early-alzheimer-s-disease-with-biomarkers-of-inflammation-61796https://curecurrent.com/trials/automated-assistive-non-contact-sleep-quality-monitor-for-individuals-with-alzheimer-s-disease-61797https://curecurrent.com/trials/remote-technologies-in-early-stages-of-alzheimer-s-disease-61798https://curecurrent.com/trials/a-clinical-trial-to-learn-about-the-effects-of-vhb937-in-people-with-early-alzheimer-s-disease-61799https://curecurrent.com/trials/the-synapse-project-61800https://curecurrent.com/trials/effects-of-ginkgo-biloba-on-blood-biomarkers-in-mild-cognitive-impairment-61801https://curecurrent.com/trials/far-infrared-therapy-for-the-effect-of-alzheimer-disease-dementia-61802https://curecurrent.com/trials/a-research-study-investigating-semaglutide-in-people-with-early-alzheimer-s-disease-evoke-plus-61803https://curecurrent.com/trials/deep-learning-on-amyloid-positons-emission-tomography-61804https://curecurrent.com/trials/persons-with-dementia-and-their-extended-family-caregivers-61805https://curecurrent.com/trials/daridorexant-to-treat-insomnia-in-patients-with-mild-cognitive-impairment-and-mild-to-moderate-alzheimer-disease-61806https://curecurrent.com/trials/deep-cervical-lymphovenous-anastomosis-for-severe-alzheimer-s-disease-61807https://curecurrent.com/trials/long-term-extension-of-phase-3-study-of-alz-801-in-apoe4-4-early-ad-subjects-61808https://curecurrent.com/trials/primary-care-detection-of-cognitive-impairment-leveraging-health-consumer-technologies-in-underserved-communities-the-my-61809https://curecurrent.com/trials/an-open-label-study-to-assess-the-long-term-safety-of-axs-05-in-subjects-with-dementia-of-the-alzheimer-s-type-advance-2-61810https://curecurrent.com/trials/blood-based-biomarkers-for-alzheimer-s-disease-at-the-primary-care-level-61811https://curecurrent.com/trials/exploration-of-the-enteric-nervous-system-in-alzheimer-disease-61812https://curecurrent.com/trials/learning-amyloid-and-tau-results-61813https://curecurrent.com/trials/allogeneic-adipose-tissue-derived-stem-cells-in-alzheimer-disease-61814https://curecurrent.com/trials/stress-and-blood-pressure-management-for-caregivers-61815https://curecurrent.com/trials/imaging-of-brain-amyloid-plaques-in-the-aging-population-61816https://curecurrent.com/trials/rhythmic-light-therapy-for-alzheimer-s-disease-patients-61817https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-kds2010-in-patients-with-alzheimer-s-disease-with-mild-cognitive-impairment-61818https://curecurrent.com/trials/deep-cervical-lymphovenous-anastomosis-for-moderate-alzheimer-s-disease-61819https://curecurrent.com/trials/cholinergic-integrity-in-down-syndrome-in-association-with-aging-alzheimer-s-disease-pathology-and-cognition-61820https://curecurrent.com/trials/a-study-of-mevidalen-ly3154207-in-participants-with-alzheimer-s-disease-61821https://curecurrent.com/trials/wearables-and-blood-based-biomarkers-incorporated-modernisation-of-circadian-rhythm-disruption-management-in-people-livi-61822https://curecurrent.com/trials/a-study-of-different-donanemab-ly3002813-dosing-regimens-in-adults-with-early-alzheimer-s-disease-trailblazer-alz-6-61823https://curecurrent.com/trials/gamma-light-and-sound-stimulation-to-prevent-dementia-in-cognitively-normal-people-at-risk-for-alzheimer-s-disease-61824https://curecurrent.com/trials/a-dyadic-sleep-health-approach-for-persons-with-alzheimer-s-disease-and-caregivers-61825https://curecurrent.com/trials/mitochondrial-function-and-metabolomic-profile-in-alzheimer-s-disease-and-related-dementias-61826https://curecurrent.com/trials/targeting-cognition-in-early-alzheimer-s-disease-by-improving-sleep-with-trazodone-61827https://curecurrent.com/trials/mima-pilot-study-microstructure-of-the-medial-temporal-lobe-in-early-alzheimer-s-disease-61828https://curecurrent.com/trials/using-artificial-intelligence-to-detect-early-signs-of-alzheimer-s-disease-in-people-with-memory-concerns-61829https://curecurrent.com/trials/automate-music-therapy-for-the-management-of-behavioral-disorders-in-nursing-homes-61830https://curecurrent.com/trials/aligning-medications-with-what-matters-most-61831https://curecurrent.com/trials/using-light-therapy-for-mild-cognitive-impairment-61832https://curecurrent.com/trials/biomarkers-in-alzheimer-s-and-parkinson-s-diseases-for-ia-61833https://curecurrent.com/trials/contribution-of-physical-activity-to-self-esteem-and-motivation-in-older-adults-with-minor-to-major-cognitive-disorders-61834https://curecurrent.com/trials/combined-tdcs-and-cognitive-training-in-alzheimer-s-61835https://curecurrent.com/trials/pilot-study-of-a-brain-health-program-in-senior-centers-61836https://curecurrent.com/trials/integrating-esage-with-ehr-data-using-machine-learning-for-the-early-detection-and-monitoring-of-cognitive-impairment-in-61837https://curecurrent.com/trials/effects-of-auditory-brain-stimulation-by-pink-noise-on-memory-capacities-in-alzheimer-s-disease-proof-of-concept-study-61838https://curecurrent.com/trials/cbd-for-individuals-at-risk-for-alzheimer-s-disease-61839https://curecurrent.com/trials/az-game-eco-economic-assessment-of-serious-games-for-the-management-of-alzheimer-s-disease-and-related-disorders-61840https://curecurrent.com/trials/intervention-to-reduce-unwanted-loneliness-in-family-caregivers-of-people-with-alzheimer-61841https://curecurrent.com/trials/evaluation-of-a-mobile-app-program-for-coping-with-cancer-61842https://curecurrent.com/trials/cholinergic-health-after-menopause-champ-61843https://curecurrent.com/trials/neuroimaging-study-61844https://curecurrent.com/trials/olfactory-biopsies-61845https://curecurrent.com/trials/virtual-reality-cognitive-stimulation-for-alzheimer-s-61846https://curecurrent.com/trials/safty-and-efficacy-of-mci-network-guided-tms-for-early-alzheimer-s-disease-a-randomized-double-blind-trial-61847https://curecurrent.com/trials/digital-lifestyle-coaching-for-alzheimer-s-disease-prevention-in-apoe4-carriers-61848https://curecurrent.com/trials/alzheimer-s-disease-therapy-with-neuroaid-ii-61849https://curecurrent.com/trials/a-study-of-ly3372689-to-assess-the-safety-tolerability-and-efficacy-in-participants-with-alzheimer-s-disease-61850https://curecurrent.com/trials/italian-validation-of-the-dna-scale-and-its-correlation-with-neurocognitive-variables-61851https://curecurrent.com/trials/a-prospective-evaluation-of-a-prescription-digital-therapeutic-for-treatment-of-overactive-bladder-in-women-the-risolve-61852https://curecurrent.com/trials/temporal-interference-stimulation-treatment-in-patients-with-cognitive-impairment-61853https://curecurrent.com/trials/pbfs-guided-rtms-treating-mild-alzheimer-s-disease-ad-61854https://curecurrent.com/trials/polyphenols-and-cognitive-decline-61855https://curecurrent.com/trials/a-study-of-the-metabolic-reconstruction-oral-biologics-gut-x-001-medication-in-people-with-alzheimer-s-disease-escape-ad-61856https://curecurrent.com/trials/silkworm-pupa-powder-improves-alzheimer-s-disease-61857https://curecurrent.com/trials/mclena-1-a-clinical-trial-for-the-assessment-of-lenalidomide-in-amnestic-mci-patients-61858https://curecurrent.com/trials/gv1001-subcutaneous-for-the-treatment-of-moderate-to-severe-alzheimer-s-disease-ad-61859https://curecurrent.com/trials/educational-support-group-program-for-bilingual-and-spanish-speaking-carepartners-and-people-with-progressive-aphasia-61860https://curecurrent.com/trials/efficacy-of-caregiver-training-program-in-enhancing-caregiver-and-patient-outcomes-61861https://curecurrent.com/trials/cognitive-reserve-and-response-to-speech-language-intervention-in-bilingual-speakers-with-primary-progressive-aphasia-61862https://curecurrent.com/trials/beta-amyloid-pet-imaging-for-alzheimer-disease-with-18f-fluselenamyl-61863https://curecurrent.com/trials/f-18-t807-tau-pet-imaging-in-dominantly-inherited-alzheimer-s-network-dian-project-61864https://curecurrent.com/trials/investigation-of-inflammation-in-alzheimer-s-disease-and-related-dementias-adrd-using-11c-cs1p1-61865https://curecurrent.com/trials/rapamycin-effects-on-alzheimer-s-and-cognitive-health-61866https://curecurrent.com/trials/fluselenamyl-beta-amyloid-pet-imaging-for-alzheimer-disease-61867https://curecurrent.com/trials/neuroimaging-in-healthy-aging-and-senile-dementia-hasd-ind-61868https://curecurrent.com/trials/biomarker-based-trial-of-npc-1-for-alzheimer-s-pathology-61869https://curecurrent.com/trials/depression-and-driving-61870https://curecurrent.com/trials/study-of-tau-imaging-with-the-use-of-18f-mk-6240-tracer-61871https://curecurrent.com/trials/silkworm-pupa-powder-improves-dementia-61872https://curecurrent.com/trials/f-18-t807-tau-pet-imaging-of-alzheimer-s-disease-61873https://curecurrent.com/trials/functional-magnetic-resonance-imaging-synthetic-aperture-magnetometry-fmri-sam-and-alzheimer-s-disease-61874https://curecurrent.com/trials/study-on-the-health-economic-burden-of-alzheimer-s-disease-in-china-61875https://curecurrent.com/trials/validation-and-reliability-of-the-turkish-version-of-the-montreal-cognitive-assessment-basic-moca-b-in-individuals-with-61876https://curecurrent.com/trials/ahead-3-45-study-a-study-to-evaluate-efficacy-and-safety-of-treatment-with-lecanemab-in-participants-with-preclinical-al-61877https://curecurrent.com/trials/crownlands-observing-progression-with-neurons-study-61878https://curecurrent.com/trials/a-study-of-ly4006895-in-healthy-participants-with-early-symptomatic-alzheimer-s-disease-ad-61879https://curecurrent.com/trials/bci-with-40hz-stimulation-in-alzheimer-s-disease-61880https://curecurrent.com/trials/implement-and-test-visual-consent-template-and-process-61881https://curecurrent.com/trials/usefulness-of-a-virtual-response-test-as-a-predictor-of-functional-and-cognitive-abilities-in-older-adults-with-differen-61882https://curecurrent.com/trials/changing-talk-online-training-chato-national-trial-61883https://curecurrent.com/trials/the-diagnose-cte-research-project-ii-61884https://curecurrent.com/trials/memory-enhancement-using-transcranial-alternating-current-stimulation-61885https://curecurrent.com/trials/reducing-burden-in-care-partners-of-community-dwelling-persons-with-dementia-and-oropharyngeal-dysphagia-61886https://curecurrent.com/trials/sleep-rhythms-and-risk-of-alzheimer-s-disease-61887https://curecurrent.com/trials/methodology-issues-in-a-tailored-light-treatment-for-persons-with-dementia-aim-2-61888https://curecurrent.com/trials/pathological-and-non-pathological-aging-physical-activity-genotype-and-cognition-61889https://curecurrent.com/trials/communication-bridge-3-study-61890https://curecurrent.com/trials/phase-2-rhythmic-light-therapy-for-alzheimer-s-disease-patients-61891https://curecurrent.com/trials/smartphone-based-cognitive-emotion-regulation-training-for-unpaid-primary-caregivers-of-persons-with-alzheimer-s-disease-61892https://curecurrent.com/trials/subjective-assessment-of-spatial-orientation-abilities-in-alzheimer-s-disease-61893https://curecurrent.com/trials/comparison-of-ai-based-smartphone-derived-gait-parameters-with-the-gold-standard-61894https://curecurrent.com/trials/multi-center-development-of-a-novel-diagnostic-test-for-alzheimer-s-disease-61895https://curecurrent.com/trials/human-mesenchymal-stem-cells-monoclonal-antibodies-in-the-treatment-for-mild-cognitive-impairment-or-early-alzheimer-s-d-61896https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-and-efficacy-of-tml-6-in-participants-with-early-alzheimer-s-disease-61897https://curecurrent.com/trials/the-inspire-faith-study-intervention-strategies-for-preserving-intellectual-resilience-and-engagement-61898https://curecurrent.com/trials/alzheimer-s-disease-stem-cells-multiple-infusions-61899https://curecurrent.com/trials/motor-slowing-and-its-lesion-related-correlates-in-alzheimer-s-disease-61900https://curecurrent.com/trials/locus-coeruleus-function-in-normal-elderly-and-ad-risk-61901https://curecurrent.com/trials/a-bct-intervention-for-an-hourly-activity-habit-among-caregivers-for-persons-with-ad-adrd-61902https://curecurrent.com/trials/18f-f-arag-pet-imaging-in-alzheimer-s-disease-61903https://curecurrent.com/trials/human-mesenchymal-stem-cells-hmsc-in-behavioral-problems-due-to-alzheimer-s-disease-61904https://curecurrent.com/trials/a-study-of-caregiver-connections-via-technology-in-dementia-61905https://curecurrent.com/trials/coordinated-emergency-department-transitions-61906https://curecurrent.com/trials/korean-brain-aging-study-for-early-diagnosis-and-prediction-of-alzheimer-s-disease2-kbase2-61907https://curecurrent.com/trials/tango-for-alzheimer-s-disease-patients-caregivers-61908https://curecurrent.com/trials/daily-light-and-sound-stimulation-to-improve-brain-functions-in-alzheimer-s-disease-61909https://curecurrent.com/trials/partnered-rhythmic-rehabilitation-in-prodromal-alzheimer-s-disease-61910https://curecurrent.com/trials/the-monument-test-a-new-tool-for-assessing-the-ability-to-name-and-identify-unique-entities-tedimo-61911https://curecurrent.com/trials/tread-time-restricted-eating-intervention-for-alzheimer-s-disease-61912https://curecurrent.com/trials/progress-of-mild-alzheimer-s-disease-in-participants-on-acupuncture-versus-sham-acupuncture-61913https://curecurrent.com/trials/18f-pi-2620-phase-3-histopathological-study-61914https://curecurrent.com/trials/bct-intervention-for-walking-habit-among-caregivers-of-people-with-ad-adrd-61915https://curecurrent.com/trials/study-to-evaluate-the-effects-of-nmra-323511-among-healthy-elderly-and-adults-with-agitation-associated-with-dementia-du-61916https://curecurrent.com/trials/effect-of-an-information-and-self-management-app-for-people-with-knee-osteoarthritis-61917https://curecurrent.com/trials/brain-attack-surveillance-in-corpus-christi-cognitive-basic-cognitive-61918https://curecurrent.com/trials/a-study-of-remternetug-ly3372993-in-participants-with-alzheimer-s-disease-trailrunner-alz-1-61919https://curecurrent.com/trials/targeting-neuroinflammation-as-a-contributing-pathology-in-alzheimer-s-disease-dementia-and-related-dementias-61920https://curecurrent.com/trials/effect-of-hypoxia-on-cognitive-assessment-and-cerebral-activity-in-healthy-volunteers-61921https://curecurrent.com/trials/the-effect-of-cb-exo-a600-in-mild-to-moderate-alzheimer-s-disease-61922https://curecurrent.com/trials/evaluation-of-the-link-between-carotid-arterial-wall-viscosity-and-major-neurocognitive-disorders-61923https://curecurrent.com/trials/neurophysiological-correlates-of-cognitive-tasks-in-healthy-volunteers-wp3-p003-61924https://curecurrent.com/trials/safety-assessment-of-leronlimab-and-its-effect-on-brain-inflammation-in-alzheimer-s-disease-61925https://curecurrent.com/trials/evaluating-the-efficacy-and-safety-of-lecanemab-in-alzheimer-s-disease-through-multi-omics-approachs-61926https://curecurrent.com/trials/the-co-production-and-evaluation-of-the-computerised-cognitive-assessment-for-preclinical-alzheimer-s-disease-cocoa-pad-61927https://curecurrent.com/trials/fareon-open-label-device-clinical-trial-61928https://curecurrent.com/trials/bac-in-patient-with-alzheimer-s-disease-or-vascular-dementia-61929https://curecurrent.com/trials/clinical-and-genetic-study-of-neurodegenerative-disorders-with-cognitive-impairment-61930https://curecurrent.com/trials/comparison-of-neuroexplorer-pet-ct-versus-standard-of-care-pet-ct-of-the-head-and-neck-region-61931https://curecurrent.com/trials/sleep-disturbance-and-emotion-regulation-brain-dysfunction-as-mechanisms-of-neuropsychiatric-symptoms-in-alzheimer-s-dem-61932https://curecurrent.com/trials/depression-in-the-elderly-and-cerebral-amyloid-plaques-characterization-by-18f-av-45-affectives-symptoms-and-amylo-d-pla-61933https://curecurrent.com/trials/expanding-access-to-cognitive-health-biomarker-testing-at-home-61934https://curecurrent.com/trials/the-brain-health-pro-online-risk-factor-reduction-study-to-prevent-dementia-61935https://curecurrent.com/trials/late-onset-alzheimer-s-disease-61936https://curecurrent.com/trials/trial-ready-cohort-down-syndrome-trc-ds-61937https://curecurrent.com/trials/a-double-blind-dual-study-assessing-safety-and-efficacy-of-buntanetap-in-participants-with-early-ad-61938https://curecurrent.com/trials/tanycytes-in-alzheimer-s-disease-and-frontotemporal-dementia-61939https://curecurrent.com/trials/assessing-cognitive-decline-at-home-61940https://curecurrent.com/trials/gapcaread-a-brief-emergency-department-intervention-to-address-post-fall-care-needs-of-persons-living-with-dementia-and-61941https://curecurrent.com/trials/amyloid-lowering-for-alzheimer-s-in-down-s-with-donanemab-investigation-61942https://curecurrent.com/trials/study-of-neural-stem-cell-derived-exosomes-in-moderate-to-severe-early-onset-alzheimer-s-disease-61943https://curecurrent.com/trials/discovery-and-validation-of-genetic-variants-affecting-microglial-activation-in-alzheimer-s-disease-61944https://curecurrent.com/trials/safety-in-dementia-an-online-caregiver-intervention-61945https://curecurrent.com/trials/tele-savvy-for-latino-caregivers-61946https://curecurrent.com/trials/efficacy-assessment-of-three-non-pharmacological-therapies-in-alzheimer-s-disease-61947https://curecurrent.com/trials/retinal-neurodegenerative-signs-in-alzheimer-s-diseases-61948https://curecurrent.com/trials/neuroimaging-markers-of-alzheimer-disease-a-longitudinal-population-study-61949https://curecurrent.com/trials/nonverbal-communication-in-aged-people-61950https://curecurrent.com/trials/reducing-suicide-risk-among-aging-caregivers-of-persons-with-ad-adrd-61951https://curecurrent.com/trials/a-phase-i-study-of-18f-flortaucipir-pet-imaging-in-chinese-subjects-safety-pharmacokinetics-biodistribution-radiation-do-61952https://curecurrent.com/trials/china-nine-cohort-neuroimmune-network-in-elderly-neurodegeneration-61953https://curecurrent.com/trials/safety-and-pharmacodynamics-of-shr-1707-in-alzheimer-s-disease-patients-61954https://curecurrent.com/trials/cardiac-control-affecting-learning-through-mindfulness-calm-61955https://curecurrent.com/trials/diagnostic-and-prognostic-value-of-new-quick-tests-of-action-slowing-in-stroke-and-in-cognitive-neurodegenerative-diseas-61956https://curecurrent.com/trials/neuronavigation-guided-fus-induced-bbb-opening-in-alzheimer-s-disease-patients-and-its-effects-on-brain-amyloid-and-tau-61957https://curecurrent.com/trials/an-open-platform-of-serious-games-for-cognitive-intervention-61958https://curecurrent.com/trials/transcranial-magnetic-stimulation-to-slow-down-cognitive-decline-in-alzheimer-s-disease-61959https://curecurrent.com/trials/deep-cervical-lymphatic-venous-anastomosis-in-the-treatment-of-alzheimer-s-disease-clean-ad-61960https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-recombinant-zoster-vaccine-on-new-diagnosis-of-dementia-in-an-older-adult-population-a-61961https://curecurrent.com/trials/safety-of-a-strategy-combining-etanercept-administration-with-repeated-contrast-ultrasound-in-patients-with-alzheimer-s-61962https://curecurrent.com/trials/a-phase-1-clinical-trial-to-investigate-the-safety-tolerability-and-pharmacokinetics-of-as-s603-in-healthy-participants-61963https://curecurrent.com/trials/patients-with-pancreatic-tumor-use-of-an-app-to-monitor-progress-in-a-simple-and-intuitive-way-by-periodically-completin-61964https://curecurrent.com/trials/integration-of-health-information-technology-and-promotion-of-personhood-in-family-centered-dementia-care-61965https://curecurrent.com/trials/mindfulness-to-enhance-cognitive-health-in-latino-older-adults-61966https://curecurrent.com/trials/alzheimer-s-imaging-biomarkers-in-obesity-61967https://curecurrent.com/trials/caring-for-caregivers-of-individuals-with-alzheimer-s-disease-61968https://curecurrent.com/trials/is-obstructive-sleep-apnea-important-in-the-development-of-alzheimer-s-disease-61969https://curecurrent.com/trials/personalized-management-of-psycho-behavioral-symptoms-in-alzheimer-s-disease-impact-on-health-resources-use-61970https://curecurrent.com/trials/lack-of-decision-making-in-patients-with-alzheimer-s-disease-functions-involved-and-the-daily-consequences-61971https://curecurrent.com/trials/eye-gaze-strategies-during-facial-emotion-recognition-in-neurodegenerative-diseases-links-with-neuropsychiatric-disorder-61972https://curecurrent.com/trials/r21-roche-3-way-tau-tracers-in-ad-61973https://curecurrent.com/trials/the-impact-of-brief-behavioral-treatment-for-insomnia-versus-brief-mindfulness-treatment-on-cognition-and-sleep-health-i-61974https://curecurrent.com/trials/memory-for-music-individual-intensive-musical-training-in-alzheimer-s-disease-61975https://curecurrent.com/trials/swallowing-impairments-in-adults-with-and-without-alzheimer-s-disease-61976https://curecurrent.com/trials/use-of-socially-assistive-robots-for-long-term-care-older-adults-with-cognitive-impairment-and-apathy-61977https://curecurrent.com/trials/repair-sleep-study-61978https://curecurrent.com/trials/cortical-disarray-measurement-in-mild-cognitive-impairment-and-alzheimer-s-disease-61979https://curecurrent.com/trials/validation-study-of-the-ex-sem-battery-designed-to-differentiate-the-contribution-of-executive-functions-in-semantic-dis-61980https://curecurrent.com/trials/the-long-term-impact-of-a-light-intervention-on-sleep-and-cognition-in-mild-cognitive-impairment-61982https://curecurrent.com/trials/music-therapy-for-patients-with-alzheimer-s-disease-61983https://curecurrent.com/trials/lifestyle-interventions-for-the-treatment-of-early-onset-alzheimer-s-disease-study-61984https://curecurrent.com/trials/the-locus-coeruleus-norepinephrine-and-cognitive-aging-61985https://curecurrent.com/trials/a-long-term-extension-study-to-assess-the-safety-of-tb006-in-participants-with-alzheimer-s-disease-61986https://curecurrent.com/trials/transcranial-magnetic-stimulation-treatment-for-alzheimer-s-disease-61987https://curecurrent.com/trials/community-based-screening-for-alzheimer-s-disease-61988https://curecurrent.com/trials/a-dynamics-in-llmd-61989https://curecurrent.com/trials/prediction-of-cognitive-properties-of-memantine-for-neurodegenerative-diseases-61990https://curecurrent.com/trials/safety-and-immunogenicity-of-repeated-doses-of-abvac40-in-patients-with-a-mci-or-vm-ad-61991https://curecurrent.com/trials/in-dementia-clinical-trials-61992https://curecurrent.com/trials/brief-problem-solving-intervention-in-different-formats-for-the-prevention-of-suicide-in-adults-over-50-61993https://curecurrent.com/trials/a-smart-trial-of-adaptive-exercises-to-optimize-aerobic-fitness-responses-61994https://curecurrent.com/trials/phase-1-study-to-evaluate-the-safety-and-tolerability-of-8m2d-in-healthy-people-and-alzheimer-s-patients-61995https://curecurrent.com/trials/a-study-of-shr-1707-with-mild-cognitive-impairment-due-to-alzheimer-s-disease-or-mild-alzheimer-s-disease-61996https://curecurrent.com/trials/validation-of-an-alzheimer-s-disease-marker-by-fecal-assay-of-amyloid-peptides-and-tau-proteins-61997https://curecurrent.com/trials/high-velocity-resistance-training-for-brain-blood-flow-and-cognitive-function-in-older-adults-61998https://curecurrent.com/trials/just-in-time-adaptive-interventions-jitais-in-a-digital-mental-health-intervention-for-middle-aged-and-older-adults-with-61999https://curecurrent.com/trials/sensory-evoked-cortical-gamma-oscillation-62000https://curecurrent.com/trials/cognitive-function-and-prevalence-of-amyloid-marker-in-frail-older-adults-62001